Species of the genus INFLUENZAVIRUS B that cause HUMAN INFLUENZA and other diseases primarily in humans. Antigenic variation is less extensive than in type A viruses (INFLUENZA A VIRUS) and consequently there is no basis for distinct subtypes or variants. Epidemics are less likely than with INFLUENZA A VIRUS and there have been no pandemics. Previously only found in humans, Influenza B virus has been isolated from seals which may constitute the animal reservoir from which humans are exposed.
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.
The type species of the genus INFLUENZAVIRUS A that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces.
Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The vaccine is usually bivalent or trivalent, containing one or two INFLUENZAVIRUS A strains and one INFLUENZAVIRUS B strain.
A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918.
A family of RNA viruses causing INFLUENZA and other diseases. There are five recognized genera: INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; ISAVIRUS; and THOGOTOVIRUS.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 3 and neuraminidase 2. The H3N2 subtype was responsible for the Hong Kong flu pandemic of 1968.
The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum.
Membrane glycoproteins from influenza viruses which are involved in hemagglutination, virus attachment, and envelope fusion. Fourteen distinct subtypes of HA glycoproteins and nine of NA glycoproteins have been identified from INFLUENZA A VIRUS; no subtypes have been identified for Influenza B or Influenza C viruses.
An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992)
Infection of domestic and wild fowl and other BIRDS with INFLUENZA A VIRUS. Avian influenza usually does not sicken birds, but can be highly pathogenic and fatal in domestic POULTRY.
Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 5 and neuraminidase 1. The H5N1 subtype, frequently referred to as the bird flu virus, is endemic in wild birds and very contagious among both domestic (POULTRY) and wild birds. It does not usually infect humans, but some cases have been reported.
Virus diseases caused by the ORTHOMYXOVIRIDAE.
Specific hemagglutinin subtypes encoded by VIRUSES.
An acetamido cyclohexene that is a structural homolog of SIALIC ACID and inhibits NEURAMINIDASE.
A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.
Ribonucleic acid that makes up the genetic material of viruses.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.
Immunoglobulins produced in response to VIRAL ANTIGENS.
Substances elaborated by viruses that have antigenic activity.
Process of growing viruses in live animals, plants, or cultured cells.
Divisions of the year according to some regularly recurrent phenomena usually astronomical or climatic. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS.
Proteins found in any species of virus.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
'Pyrans' are heterocyclic organic compounds containing a six-membered ring with one oxygen atom and five carbon atoms, which can be found in various natural substances and synthesized compounds, and may have potential applications in medicinal chemistry.
Viruses containing two or more pieces of nucleic acid (segmented genome) from different parents. Such viruses are produced in cells coinfected with different strains of a given virus.
A general term for diseases produced by viruses.
INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Established cell cultures that have the potential to propagate indefinitely.
Viruses whose genetic material is RNA.
Proteins conjugated with nucleic acids.
A genus of the family ORTHOMYXOVIRIDAE comprising viruses similar to types A and B but less common, more stable, more homogeneous, and lacking the neuraminidase protein. They have not been associated with epidemics but may cause mild influenza. Influenza C virus is the type species.
Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people.
The top portion of the pharynx situated posterior to the nose and superior to the SOFT PALATE. The nasopharynx is the posterior extension of the nasal cavities and has a respiratory function.
The study of the structure, growth, function, genetics, and reproduction of viruses, and VIRUS DISEASES.
The functional hereditary units of VIRUSES.
Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins.
The relationships of groups of organisms as reflected by their genetic makeup.
An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.
Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.
The expelling of virus particles from the body. Important routes include the respiratory tract, genital tract, and intestinal tract. Virus shedding is an important means of vertical transmission (INFECTIOUS DISEASE TRANSMISSION, VERTICAL).
A DNA virus that closely resembles human hepatitis B virus. It has been recovered from naturally infected ducks.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 9 and neuraminidase 2. The H9N2 subtype usually infects domestic birds (POULTRY) but there have been some human infections reported.
Proteins associated with the inner surface of the lipid bilayer of the viral envelope. These proteins have been implicated in control of viral transcription and may possibly serve as the "glue" that binds the nucleocapsid to the appropriate membrane site during viral budding from the host cell.
The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS.
Deoxyribonucleic acid that makes up the genetic material of viruses.
The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50).
Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response.
A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 3 and neuraminidase 8. The H3N8 subtype has frequently been found in horses.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 7 and neuraminidase 7. The H7N7 subtype produced an epidemic in 2003 which was highly pathogenic among domestic birds (POULTRY). Some infections in humans were reported.
Proteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the NUCLEOCAPSID.
Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort such as in a geographic area or population subgroup to estimate trends in a larger population. (From Last, Dictionary of Epidemiology, 2d ed)
A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
Proteins encoded by a VIRAL GENOME that are produced in the organisms they infect, but not packaged into the VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY.
Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
The infective system of a virus, composed of the viral genome, a protein core, and a protein coat called a capsid, which may be naked or enclosed in a lipoprotein envelope called the peplos.
The assembly of VIRAL STRUCTURAL PROTEINS and nucleic acid (VIRAL DNA or VIRAL RNA) to form a VIRUS PARTICLE.
Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity.
A species of RESPIROVIRUS also called hemadsorption virus 2 (HA2), which causes laryngotracheitis in humans, especially children.
A genus in the family ORTHOMYXOVIRIDAE causing influenza and other diseases in humans and animals. It contains many strains as well as antigenic subtypes of the integral membrane proteins hemagglutinin (HEMAGGLUTININS) and NEURAMINIDASE. The type species is INFLUENZA A VIRUS.
Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey (C. pygerythrus) is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 2 and neuraminidase 2. The H2N2 subtype was responsible for the Asian flu pandemic of 1957.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 7 and neuraminidase 9. This avian origin virus was first identified in humans in 2013.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 5 and neuraminidase 2. The H5N2 subtype has been found to be highly pathogenic in chickens.
The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching.
Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE.
A species of RESPIROVIRUS frequently isolated from small children with pharyngitis, bronchitis, and pneumonia.
A group of naturally occurring N-and O-acyl derivatives of the deoxyamino sugar neuraminic acid. They are ubiquitously distributed in many tissues.
A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis.
The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion.
Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc.
Warm-blooded VERTEBRATES possessing FEATHERS and belonging to the class Aves.
INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
Semidomesticated variety of European polecat much used for hunting RODENTS and/or RABBITS and as a laboratory animal. It is in the subfamily Mustelinae, family MUSTELIDAE.
An enzyme that catalyses RNA-template-directed extension of the 3'- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. (Enzyme Nomenclature, 1992, p293)
A species of POLYOMAVIRUS originally isolated from Rhesus monkey kidney tissue. It produces malignancy in human and newborn hamster kidney cell cultures.
Viruses which lack a complete genome so that they cannot completely replicate or cannot form a protein coat. Some are host-dependent defectives, meaning they can replicate only in cell systems which provide the particular genetic function which they lack. Others, called SATELLITE VIRUSES, are able to replicate only when their genetic defect is complemented by a helper virus.
Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells.
A species of RUBULAVIRUS associated particularly with acute laryngotracheitis (CROUP) in children aged 6 months to 3 years.
A genus of the family ORTHOMYXOVIRUS causing HUMAN INFLUENZA and other diseases primarily in humans. In contrast to INFLUENZAVIRUS A, no distinct antigenic subtypes of hemagglutinin (HEMAGGLUTININS) and NEURAMINIDASE are recognized.
Viruses whose nucleic acid is DNA.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 1 and neuraminidase 2. It is endemic in both human and pig populations.
Viruses parasitic on plants higher than bacteria.
A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G.
Change in the surface ANTIGEN of a microorganism. There are two different types. One is a phenomenon, especially associated with INFLUENZA VIRUSES, where they undergo spontaneous variation both as slow antigenic drift and sudden emergence of new strains (antigenic shift). The second type is when certain PARASITES, especially trypanosomes, PLASMODIUM, and BORRELIA, survive the immune response of the host by changing the surface coat (antigen switching). (From Herbert et al., The Dictionary of Immunology, 4th ed)
A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.
Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.
Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens.
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
The type species of ALPHAVIRUS normally transmitted to birds by CULEX mosquitoes in Egypt, South Africa, India, Malaya, the Philippines, and Australia. It may be associated with fever in humans. Serotypes (differing by less than 17% in nucleotide sequence) include Babanki, Kyzylagach, and Ockelbo viruses.
The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells.
The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children.
Viral proteins found in either the NUCLEOCAPSID or the viral core (VIRAL CORE PROTEINS).
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Genotypic differences observed among individuals in a population.
Sites on an antigen that interact with specific antibodies.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Elements of limited time intervals, contributing to particular results or situations.
Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses.
The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish, enhance, or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.
"Ducks" is not a recognized medical term or condition in human health; it may refer to various anatomical structures in animals, such as the ducks of the heart valves, but it does not have a standalone medical definition.
The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates.
Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1.
The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species.
A CELL LINE derived from the kidney of the African green (vervet) monkey, (CERCOPITHECUS AETHIOPS) used primarily in virus replication studies and plaque assays.
The mechanism by which latent viruses, such as genetically transmitted tumor viruses (PROVIRUSES) or PROPHAGES of lysogenic bacteria, are induced to replicate and then released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell LIPOPOLYSACCHARIDES, glucocorticoid hormones, halogenated pyrimidines, IONIZING RADIATION, ultraviolet light, and superinfecting viruses.
A group of alicyclic hydrocarbons with the general formula R-C5H9.
Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
Short sequences (generally about 10 base pairs) of DNA that are complementary to sequences of messenger RNA and allow reverse transcriptases to start copying the adjacent sequences of mRNA. Primers are used extensively in genetic and molecular biology techniques.
The complete genetic complement contained in a DNA or RNA molecule in a virus.
A family of proteins that are structurally-related to Ubiquitin. Ubiquitins and ubiquitin-like proteins participate in diverse cellular functions, such as protein degradation and HEAT-SHOCK RESPONSE, by conjugation to other proteins.
Antibodies produced by a single clone of cells.
An epithelial cell line derived from a kidney of a normal adult female dog.
Inbred BALB/c mice are a strain of laboratory mice that have been selectively bred to be genetically identical to each other, making them useful for scientific research and experiments due to their consistent genetic background and predictable responses to various stimuli or treatments.
## I'm sorry for any confusion, but "Japan" is not a medical term or concept. It is a country located in Asia, known as Nihon-koku or Nippon-koku in Japanese, and is renowned for its unique culture, advanced technology, and rich history. If you have any questions related to medical topics, I would be happy to help answer them!
A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE). It can infect birds and mammals. In humans, it is seen most frequently in Africa, Asia, and Europe presenting as a silent infection or undifferentiated fever (WEST NILE FEVER). The virus appeared in North America for the first time in 1999. It is transmitted mainly by CULEX spp mosquitoes which feed primarily on birds, but it can also be carried by the Asian Tiger mosquito, AEDES albopictus, which feeds mainly on mammals.
Domesticated birds raised for food. It typically includes CHICKENS; TURKEYS, DUCKS; GEESE; and others.
I'm sorry for any confusion, but "Taiwan" is not a medical term and does not have a medical definition. It is a country located in East Asia. If you have any questions related to healthcare or medical terms, I would be happy to help with those!
Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses.
The process of cumulative change at the level of DNA; RNA; and PROTEINS, over successive generations.

Comparative analysis of evolutionary mechanisms of the hemagglutinin and three internal protein genes of influenza B virus: multiple cocirculating lineages and frequent reassortment of the NP, M, and NS genes. (1/825)

Phylogenetic profiles of the genes coding for the hemagglutinin (HA) protein, nucleoprotein (NP), matrix (M) protein, and nonstructural (NS) proteins of influenza B viruses isolated from 1940 to 1998 were analyzed in a parallel manner in order to understand the evolutionary mechanisms of these viruses. Unlike human influenza A (H3N2) viruses, the evolutionary pathways of all four genes of recent influenza B viruses revealed similar patterns of genetic divergence into two major lineages. Although evolutionary rates of the HA, NP, M, and NS genes of influenza B viruses were estimated to be generally lower than those of human influenza A viruses, genes of influenza B viruses demonstrated complex phylogenetic patterns, indicating alternative mechanisms for generation of virus variability. Topologies of the evolutionary trees of each gene were determined to be quite distinct from one another, showing that these genes were evolving in an independent manner. Furthermore, variable topologies were apparently the result of frequent genetic exchange among cocirculating epidemic viruses. Evolutionary analysis done in the present study provided further evidence for cocirculation of multiple lineages as well as sequestering and reemergence of phylogenetic lineages of the internal genes. In addition, comparison of deduced amino acid sequences revealed a novel amino acid deletion in the HA1 domain of the HA protein of recent isolates from 1998 belonging to the B/Yamagata/16/88-like lineage. It thus became apparent that, despite lower evolutionary rates, influenza B viruses were able to generate genetic diversity among circulating viruses through a combination of evolutionary mechanisms involving cocirculating lineages and genetic reassortment by which new variants with distinct gene constellations emerged.  (+info)

Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis. (2/825)

BACKGROUND: Infectious respiratory disorders are important causes of childhood morbidity and mortality. Viral causes are common and may lead to rapid deterioration, requiring mechanical ventilation; myocardial dysfunction may accompany respiratory decompensation. The etiologic viral diagnosis may be difficult with classic methods. The purpose of this study was to evaluate polymerase chain reaction (PCR) as a diagnostic method for identification of causative agents. METHODS AND RESULTS: PCR was used to amplify sequences of viruses known to cause childhood viral pneumonia and myocarditis. Oligonucleotide primers were designed to amplify specific sequences of DNA virus (adenovirus, cytomegalovirus, herpes simplex virus, and Epstein-Barr virus) and RNA virus (enterovirus, respiratory syncytial virus, influenza A, and influenza B) genomes. Tracheal aspirate samples were obtained from 32 intubated patients and nucleic acid extracted before PCR. PCR results were compared with results of culture, serology, and antigen detection methods when available. In cases of myocarditis (n=7), endomyocardial biopsy samples were analyzed by PCR and compared with tracheal aspirate studies. PCR amplification of viral genome occurred in 18 of 32 samples (56%), with 3 samples PCR positive for 2 viral genomes. Amplified viral sequences included RSV (n=3), enterovirus (n=5), cytomegalovirus (n=4), adenovirus (n=3), herpes simplex virus (n=2), Epstein-Barr virus (n=1), influenza A (n=2), and influenza B (n=1). All 7 cases of myocarditis amplified the same viral genome from heart as found by tracheal aspirate. CONCLUSIONS: PCR is a rapid and sensitive diagnostic tool in cases of viral pneumonia with or without myocarditis, and tracheal aspirate appears to be excellent for analysis.  (+info)

Coinfection with influenza B virus does not affect association of Neisseria meningitidis with human nasopharyngeal mucosa in organ culture. (3/825)

There is an epidemiological association between influenza virus infection and meningococcal disease. Proposed mechanisms are the destruction of the normal epithelial barrier function of the upper respiratory tract by influenza virus or the expression of human or viral surface-exposed proteins that enhance bacterial adherence and/or invasion. To test these hypotheses, human nasopharyngeal mucosa specimens from a total of 19 individual donors were successfully infected with influenza B virus and then inoculated with serogroup B Neisseria meningitidis. Subsequent bacterial association with the epithelial surface was measured in three separate series of experiments by using transmission electron microscopy (n = 6), scanning electron microscopy (n = 6), and counting of viable bacteria within homogenates of explants (n = 7). Penetration of the mucosa was estimated by measuring the count of viable bacteria recovered from explants after exposure to sodium taurocholate. Bacterial association with the surface of explants was time dependent over 24 h of superinfection. Influenza virus did not positively or negatively influence bacterial attachment to or penetration of explant mucosa compared to those of uninfected controls, even when the period of preincubation with virus was extended to 7 days. When proteins were purified from mucosal epithelium and immobilized on nitrocellulose membranes, N. meningitidis attached predominantly to bands corresponding to proteins of 210 and 130 kDa. In the presence of influenza virus infection, these proteins were gradually lost over the course of 72 h. In conclusion, influenza B virus did not increase association of serogroup B N. meningitidis with human nasopharyngeal mucosa.  (+info)

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). (4/825)

This report updates 1998 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 1998;47[No. RR-6]:1-26). The principal changes include a) information on the influenza virus strains included in the 1999-2000 trivalent vaccine; b) discussion of the potential expanded use of influenza vaccine; c) new background information on live-attenuated influenza vaccines (LAIVs), neuraminidase-inhibitor drugs, and rapid diagnostic tests; d) new information on the epidemiology of influenza among travelers; and e) the addition of referenced citations. This report and other information on influenza can be accessed at the website for the Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC at .  (+info)

Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. (5/825)

Propagation of human influenza viruses in embryonated chicken eggs (CE) results in the selection of variants with amino acid substitutions near the receptor-binding site of the hemagglutinin (HA) molecule. To evaluate the mechanisms by which these substitutions enable human virus growth in CE, we studied the binding of 10 human influenza A (H1N1, H3N2) and B strains, isolated and propagated solely in MDCK cells, and of their egg-adapted counterparts to preparations of cellular membranes, gangliosides, sialylglycoproteins, and sialyloligosaccharides. All egg-adapted variants differed from nonadapted strains by increased binding to the plasma membranes of chorio-allantoic (CAM) cells of CE and by the ability to bind to CAM gangliosides. In addition, there was no decrease in affinity for inhibitors within allantoic fluid. These findings indicate that growth of human influenza viruses in CE is restricted because of their inefficient binding to receptors on CAM cells and that gangliosides can play an important role in virus binding and/or penetration. The effects of the egg-adaptation substitutions on the receptor-binding properties of the viruses include (i) enhancement of virus binding to the terminal Sia(alpha2-3)Gal determinant (substitutions in HA positions 190, 225 of H1N1 strains and in position 186 of H3N2 strains); (ii) a decrease of steric interference with more distant parts of the Sia(alpha2-3Gal)-containing receptors (a loss of glycosylation sites in positions 163 of H1 HA and 187 of type B HA); and (iii) enhanced ionic interactions with the negatively charged molecules due to charged substitutions at the tip of the HA [187, 189, 190 (H1), and 145, 156 (H3)]. Concomitantly with enhanced binding to Sia(alpha2-3)Gal-terminated receptors, all egg-adapted variants decreased their affinity for equine macroglobulin, a glycoprotein bearing terminal 6'-sialyl(N-acetyllactosamine)-moieties.  (+info)

Update: influenza activity--United States and worldwide, 1998-99 season, and composition of the 1999-2000 influenza vaccine. (6/825)

In collaboration with the World Health Organization (WHO), the WHO international network of collaborating laboratories, and state and local health departments, CDC conducts surveillance to monitor influenza activity and to detect antigenic changes in the circulating strains of influenza viruses. This report summarizes surveillance for influenza in the United States and worldwide during the 1998-99 influenza season and describes the composition of the 1999-2000 influenza vaccine.  (+info)

Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection. (7/825)

Influenza virus is characterized by frequent and unpredictable changes of the surface glycoproteins which enable the virus to escape the immune system. Approved vaccines which consist of the whole virus or the surface glycoproteins fail to induce broad specificity protection. We have previously reported that a peptide-based experimental recombinant vaccine which includes conserved epitopes of B and T lymphocytes was efficient in mice, leading to cross-strain, long-term protection. In the present study, this approach was adapted for the design of a human vaccine, based on epitopes recognized by the prevalent HLAs. These epitopes were expressed in Salmonella flagellin and tested for their efficacy in human/mouse radiation chimera in which human peripheral blood mononuclear cells (PBMC) are functionally engrafted. The vaccinated mice demonstrated clearance of the virus after challenge and resistance to lethal infection. The production of virus-specific human antibodies was also higher in this group. Control groups of either non-vaccinated, or vaccinated mice which had not been engrafted with the human PBMC, did not exhibit the protective immune response. FACS analysis showed that most human cells in the transplanted mice are CD8(+) and CD4(+). Hence, it may be concluded: (i) that the protection involves cellular mechanisms, but is most probably accomplished without direct lysis of influenza-infected pulmonary cells by cytotoxic T lymphocytes, but rather via a cytokine-mediated mechanism, (ii) that the human/mouse radiation chimera model may be of some value in the investigation of new vaccines, as an additional tool prior to clinical trials, and (iii) that the synthetic recombinant vaccine can induce a response in the human immune system and confers protection against influenza infection. Further investigation is needed to establish the efficacy of such a peptide vaccine in human subjects.  (+info)

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. (8/825)

The efficacy and safety of zanamivir, administered 2x or 4x daily over 5 days, was evaluated in the treatment of influenza infections. A total of 1256 patients entered the study; 57% of those randomized had laboratory-confirmed influenza infection. The primary end point, "alleviation of major symptoms," was created to evaluate differences in clinical impact. In the overall population with or without influenza infection, zanamivir reduced the median number of days to reach this end point by 1 day (P=.012 2x daily vs. placebo; P=.014 4x daily vs. placebo). The reduction was greater in patients treated within 30 h of symptom onset, febrile at study entry, and in defined high-risk groups. Zanamivir reduced nights of disturbed sleep, time to resumption of normal activities, and use of symptom relief medications. It was well tolerated. These results suggest that zanamivir can significantly reduce the duration and overall symptomatic effect of influenza.  (+info)

Influenza B virus is one of the primary types of influenza viruses that cause seasonal flu in humans. It's an enveloped, negative-sense, single-stranded RNA virus belonging to the family Orthomyxoviridae.

Influenza B viruses are typically found only in humans and circulate widely during the annual flu season. They mutate at a slower rate than Influenza A viruses, which means that immunity developed against one strain tends to provide protection against similar strains in subsequent seasons. However, they can still cause significant illness, especially among young children, older adults, and people with certain chronic medical conditions.

Influenza B viruses are divided into two lineages: Victoria and Yamagata. Vaccines are developed each year to target the most likely strains of Influenza A and B viruses that will circulate in the upcoming flu season.

Influenza, also known as the flu, is a highly contagious viral infection that attacks the respiratory system of humans. It is caused by influenza viruses A, B, or C and is characterized by the sudden onset of fever, chills, headache, muscle pain, sore throat, cough, runny nose, and fatigue. Influenza can lead to complications such as pneumonia, bronchitis, and ear infections, and can be particularly dangerous for young children, older adults, pregnant women, and people with weakened immune systems or chronic medical conditions. The virus is spread through respiratory droplets produced when an infected person coughs, sneezes, or talks, and can also survive on surfaces for a period of time. Influenza viruses are constantly changing, which makes it necessary to get vaccinated annually to protect against the most recent and prevalent strains.

Influenza A virus is defined as a negative-sense, single-stranded, segmented RNA virus belonging to the family Orthomyxoviridae. It is responsible for causing epidemic and pandemic influenza in humans and is also known to infect various animal species, such as birds, pigs, horses, and seals. The viral surface proteins, hemagglutinin (HA) and neuraminidase (NA), are the primary targets for antiviral drugs and vaccines. There are 18 different HA subtypes and 11 known NA subtypes, which contribute to the diversity and antigenic drift of Influenza A viruses. The zoonotic nature of this virus allows for genetic reassortment between human and animal strains, leading to the emergence of novel variants with pandemic potential.

Influenza vaccines, also known as flu shots, are vaccines that protect against the influenza virus. Influenza is a highly contagious respiratory illness that can cause severe symptoms and complications, particularly in young children, older adults, pregnant women, and people with certain underlying health conditions.

Influenza vaccines contain inactivated or weakened viruses or pieces of the virus, which stimulate the immune system to produce antibodies that recognize and fight off the virus. The vaccine is typically given as an injection into the muscle, usually in the upper arm.

There are several different types of influenza vaccines available, including:

* Trivalent vaccines, which protect against three strains of the virus (two A strains and one B strain)
* Quadrivalent vaccines, which protect against four strains of the virus (two A strains and two B strains)
* High-dose vaccines, which contain a higher amount of antigen and are recommended for people aged 65 and older
* Adjuvanted vaccines, which contain an additional ingredient to boost the immune response and are also recommended for people aged 65 and older
* Cell-based vaccines, which are produced using cultured cells rather than eggs and may be recommended for people with egg allergies

It's important to note that influenza viruses are constantly changing, so the vaccine is updated each year to match the circulating strains. It's recommended that most people get vaccinated against influenza every year to stay protected.

'Influenza A Virus, H1N1 Subtype' is a specific subtype of the influenza A virus that causes flu in humans and animals. It contains certain proteins called hemagglutinin (H) and neuraminidase (N) on its surface, with this subtype specifically having H1 and N1 antigens. The H1N1 strain is well-known for causing the 2009 swine flu pandemic, which was a global outbreak of flu that resulted in significant morbidity and mortality. This subtype can also cause seasonal flu, although the severity and symptoms may vary. It is important to note that influenza viruses are constantly changing, and new strains or subtypes can emerge over time, requiring regular updates to vaccines to protect against them.

Orthomyxoviridae is a family of viruses that includes influenza A, B, and C viruses, which are the causative agents of flu in humans and animals. These viruses are enveloped, meaning they have a lipid membrane derived from the host cell, and have a single-stranded, negative-sense RNA genome. The genome is segmented, meaning it consists of several separate pieces of RNA, which allows for genetic reassortment or "shuffling" when two different strains infect the same cell, leading to the emergence of new strains.

The viral envelope contains two major glycoproteins: hemagglutinin (HA) and neuraminidase (NA). The HA protein is responsible for binding to host cells and facilitating entry into the cell, while NA helps release newly formed virus particles from infected cells by cleaving sialic acid residues on the host cell surface.

Orthomyxoviruses are known to cause respiratory infections in humans and animals, with influenza A viruses being the most virulent and capable of causing pandemics. Influenza B viruses typically cause less severe illness and are primarily found in humans, while influenza C viruses generally cause mild upper respiratory symptoms and are also mainly restricted to humans.

"Influenza A Virus, H3N2 Subtype" is a specific subtype of the influenza A virus that causes respiratory illness and is known to circulate in humans and animals, including birds and pigs. The "H3N2" refers to the two proteins on the surface of the virus: hemagglutinin (H) and neuraminidase (N). In this subtype, the H protein is of the H3 variety and the N protein is of the N2 variety. This subtype has been responsible for several influenza epidemics and pandemics in humans, including the 1968 Hong Kong flu pandemic. It is one of the influenza viruses that are monitored closely by public health authorities due to its potential to cause significant illness and death, particularly in high-risk populations such as older adults, young children, and people with certain underlying medical conditions.

Hepatitis B virus (HBV) is a DNA virus that belongs to the Hepadnaviridae family and causes the infectious disease known as hepatitis B. This virus primarily targets the liver, where it can lead to inflammation and damage of the liver tissue. The infection can range from acute to chronic, with chronic hepatitis B increasing the risk of developing serious liver complications such as cirrhosis and liver cancer.

The Hepatitis B virus has a complex life cycle, involving both nuclear and cytoplasmic phases. It enters hepatocytes (liver cells) via binding to specific receptors and is taken up by endocytosis. The viral DNA is released into the nucleus, where it is converted into a covalently closed circular DNA (cccDNA) form, which serves as the template for viral transcription.

HBV transcribes several RNAs, including pregenomic RNA (pgRNA), which is used as a template for reverse transcription during virion assembly. The pgRNA is encapsidated into core particles along with the viral polymerase and undergoes reverse transcription to generate new viral DNA. This process occurs within the cytoplasm of the hepatocyte, resulting in the formation of immature virions containing partially double-stranded DNA.

These immature virions are then enveloped by host cell membranes containing HBV envelope proteins (known as surface antigens) to form mature virions that can be secreted from the hepatocyte and infect other cells. The virus can also integrate into the host genome, which may contribute to the development of hepatocellular carcinoma in chronic cases.

Hepatitis B is primarily transmitted through exposure to infected blood or bodily fluids containing the virus, such as through sexual contact, sharing needles, or from mother to child during childbirth. Prevention strategies include vaccination, safe sex practices, and avoiding needle-sharing behaviors. Treatment for hepatitis B typically involves antiviral medications that can help suppress viral replication and reduce the risk of liver damage.

Hemagglutinin (HA) glycoproteins are surface proteins found on influenza viruses. They play a crucial role in the virus's ability to infect and spread within host organisms.

The HAs are responsible for binding to sialic acid receptors on the host cell's surface, allowing the virus to attach and enter the cell. After endocytosis, the viral and endosomal membranes fuse, releasing the viral genome into the host cell's cytoplasm.

There are several subtypes of hemagglutinin (H1-H18) identified so far, with H1, H2, and H3 being common in human infections. The significant antigenic differences among these subtypes make them important targets for the development of influenza vaccines. However, due to their high mutation rate, new vaccine formulations are often required to match the circulating virus strains.

In summary, hemagglutinin glycoproteins on influenza viruses are essential for host cell recognition and entry, making them important targets for diagnosis, prevention, and treatment of influenza infections.

Neuraminidase is an enzyme that occurs on the surface of influenza viruses. It plays a crucial role in the life cycle of the virus by helping it to infect host cells and to spread from cell to cell within the body. Neuraminidase works by cleaving sialic acid residues from glycoproteins, allowing the virus to detach from infected cells and to move through mucus and other bodily fluids. This enzyme is a major target of antiviral drugs used to treat influenza, such as oseltamivir (Tamiflu) and zanamivir (Relenza). Inhibiting the activity of neuraminidase can help to prevent the spread of the virus within the body and reduce the severity of symptoms.

'Avian influenza' refers to the infection caused by avian (bird) influenza A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian influenza viruses do not normally infect humans, but rare cases of human infection have occurred mainly after close contact with infected birds or heavily contaminated environments.

There are many different subtypes of avian influenza viruses based on two proteins on the surface of the virus: hemagglutinin (HA) and neuraminidase (NA). There are 16 known HA subtypes and 9 known NA subtypes, creating a vast number of possible combinations. Some of these combinations cause severe disease and death in birds (e.g., H5N1, H7N9), while others only cause mild illness (e.g., H9N2).

Most avian influenza viruses do not infect humans. However, some forms are zoonotic, meaning they can infect animals and humans. The risk to human health is generally low. When human infections with avian influenza viruses have occurred, most have resulted from direct contact with infected poultry or surfaces contaminated by their feces.

Avian influenza viruses have caused several pandemics in the past, including the 1918 Spanish flu (H1N1), which was an H1N1 virus containing genes of avian origin. The concern is that a highly pathogenic avian influenza virus could mutate to become easily transmissible from human to human, leading to another pandemic. This is one of the reasons why avian influenza viruses are closely monitored by public health authorities worldwide.

Hemagglutination inhibition (HI) tests are a type of serological assay used in medical laboratories to detect and measure the amount of antibodies present in a patient's serum. These tests are commonly used to diagnose viral infections, such as influenza or HIV, by identifying the presence of antibodies that bind to specific viral antigens and prevent hemagglutination (the agglutination or clumping together of red blood cells).

In an HI test, a small amount of the patient's serum is mixed with a known quantity of the viral antigen, which has been treated to attach to red blood cells. If the patient's serum contains antibodies that bind to the viral antigen, they will prevent the antigen from attaching to the red blood cells and inhibit hemagglutination. The degree of hemagglutination inhibition can be measured and used to estimate the amount of antibody present in the patient's serum.

HI tests are relatively simple and inexpensive to perform, but they have some limitations. For example, they may not detect early-stage infections before the body has had a chance to produce antibodies, and they may not be able to distinguish between different strains of the same virus. Nonetheless, HI tests remain an important tool for diagnosing viral infections and monitoring immune responses to vaccination or infection.

"Influenza A Virus, H5N1 Subtype" is a specific subtype of the Influenza A virus that is often found in avian species (birds) and can occasionally infect humans. The "H5N1" refers to the specific proteins (hemagglutinin and neuraminidase) found on the surface of the virus. This subtype has caused serious infections in humans, with high mortality rates, especially in cases where people have had close contact with infected birds. It does not commonly spread from person to person, but there is concern that it could mutate and adapt to efficiently transmit between humans, which would potentially cause a pandemic.

Orthomyxoviridae is a family of viruses that includes influenza A, B, and C viruses, which can cause respiratory infections in humans. Orthomyxoviridae infections are typically characterized by symptoms such as fever, cough, sore throat, runny or stuffy nose, muscle or body aches, headaches, and fatigue.

Influenza A and B viruses can cause seasonal epidemics of respiratory illness that occur mainly during the winter months in temperate climates. Influenza A viruses can also cause pandemics, which are global outbreaks of disease that occur when a new strain of the virus emerges to which there is little or no immunity in the human population.

Influenza C viruses are less common and typically cause milder illness than influenza A and B viruses. They do not cause epidemics and are not usually included in seasonal flu vaccines.

Orthomyxoviridae infections can be prevented through vaccination, good respiratory hygiene (such as covering the mouth and nose when coughing or sneezing), hand washing, and avoiding close contact with sick individuals. Antiviral medications may be prescribed to treat influenza A and B infections, particularly for people at high risk of complications, such as older adults, young children, pregnant women, and people with certain underlying medical conditions.

Hemagglutinins are glycoprotein spikes found on the surface of influenza viruses. They play a crucial role in the viral infection process by binding to sialic acid receptors on host cells, primarily in the respiratory tract. After attachment, hemagglutinins mediate the fusion of the viral and host cell membranes, allowing the viral genome to enter the host cell and initiate replication.

There are 18 different subtypes of hemagglutinin (H1-H18) identified in influenza A viruses, which naturally infect various animal species, including birds, pigs, and humans. The specificity of hemagglutinins for particular sialic acid receptors can influence host range and tissue tropism, contributing to the zoonotic potential of certain influenza A virus subtypes.

Hemagglutination inhibition (HI) assays are commonly used in virology and epidemiology to measure the antibody response to influenza viruses and determine vaccine effectiveness. In these assays, hemagglutinins bind to red blood cells coated with sialic acid receptors, forming a diffuse mat of cells that can be observed visually. The addition of specific antisera containing antibodies against the hemagglutinin prevents this binding and results in the formation of discrete buttons of red blood cells, indicating a positive HI titer and the presence of neutralizing antibodies.

Oseltamivir is an antiviral medication used to treat and prevent influenza A and B infections. It works by inhibiting the neuraminidase enzyme, which plays a crucial role in the replication of the influenza virus. By blocking this enzyme, oseltamivir prevents the virus from spreading within the body, thereby reducing the severity and duration of flu symptoms.

Oseltamivir is available as a phosphate salt, known as oseltamivir phosphate, which is converted into its active form, oseltamivir carboxylate, after oral administration. It is typically administered orally in the form of capsules or a powder for suspension.

It's important to note that oseltamivir is most effective when started within 48 hours of symptom onset. While it can reduce the duration of flu symptoms by about one to two days, it does not cure the infection and may not prevent serious complications in high-risk individuals, such as those with underlying medical conditions or weakened immune systems.

Common side effects of oseltamivir include nausea, vomiting, diarrhea, and headache. Serious side effects are rare but can include allergic reactions, skin rashes, and neuropsychiatric events like confusion, hallucinations, and abnormal behavior. Consult a healthcare professional for more detailed information about oseltamivir and its potential uses, benefits, and risks.

Zanamivir is an antiviral medication used to treat and prevent influenza A and B infections. It works by blocking the action of influenza viral neuraminidase, which helps the virus to spread and infect other cells. By inhibiting this enzyme, zanamivir prevents the virus from replicating and thus reduces the severity and duration of flu symptoms.

Zanamivir is available as an inhalation powder and is usually administered using a device called a diskhaler. It is important to note that zanamivir is not effective against other viral or bacterial infections, and it should be used as soon as possible after the onset of flu symptoms for the best results.

As with any medication, zanamivir can have side effects, including respiratory problems such as bronchospasm, cough, and shortness of breath. It may also cause nausea, vomiting, and headaches. People with a history of respiratory disorders, such as asthma or chronic obstructive pulmonary disease (COPD), should use zanamivir with caution, as it may exacerbate these conditions.

Zanamivir is not recommended for people with severe allergies to any ingredient in the medication, and it should be used with caution in pregnant or breastfeeding women, children under seven years of age, and people with kidney or liver disease. It is important to consult a healthcare provider before taking zanamivir or any other medication.

A viral RNA (ribonucleic acid) is the genetic material found in certain types of viruses, as opposed to viruses that contain DNA (deoxyribonucleic acid). These viruses are known as RNA viruses. The RNA can be single-stranded or double-stranded and can exist as several different forms, such as positive-sense, negative-sense, or ambisense RNA. Upon infecting a host cell, the viral RNA uses the host's cellular machinery to translate the genetic information into proteins, leading to the production of new virus particles and the continuation of the viral life cycle. Examples of human diseases caused by RNA viruses include influenza, COVID-19 (SARS-CoV-2), hepatitis C, and polio.

Antiviral agents are a class of medications that are designed to treat infections caused by viruses. Unlike antibiotics, which target bacteria, antiviral agents interfere with the replication and infection mechanisms of viruses, either by inhibiting their ability to replicate or by modulating the host's immune response to the virus.

Antiviral agents are used to treat a variety of viral infections, including influenza, herpes simplex virus (HSV) infections, human immunodeficiency virus (HIV) infection, hepatitis B and C, and respiratory syncytial virus (RSV) infections.

These medications can be administered orally, intravenously, or topically, depending on the type of viral infection being treated. Some antiviral agents are also used for prophylaxis, or prevention, of certain viral infections.

It is important to note that antiviral agents are not effective against all types of viruses and may have significant side effects. Therefore, it is essential to consult with a healthcare professional before starting any antiviral therapy.

Virus replication is the process by which a virus produces copies or reproduces itself inside a host cell. This involves several steps:

1. Attachment: The virus attaches to a specific receptor on the surface of the host cell.
2. Penetration: The viral genetic material enters the host cell, either by invagination of the cell membrane or endocytosis.
3. Uncoating: The viral genetic material is released from its protective coat (capsid) inside the host cell.
4. Replication: The viral genetic material uses the host cell's machinery to produce new viral components, such as proteins and nucleic acids.
5. Assembly: The newly synthesized viral components are assembled into new virus particles.
6. Release: The newly formed viruses are released from the host cell, often through lysis (breaking) of the cell membrane or by budding off the cell membrane.

The specific mechanisms and details of virus replication can vary depending on the type of virus. Some viruses, such as DNA viruses, use the host cell's DNA polymerase to replicate their genetic material, while others, such as RNA viruses, use their own RNA-dependent RNA polymerase or reverse transcriptase enzymes. Understanding the process of virus replication is important for developing antiviral therapies and vaccines.

Antibodies, viral are proteins produced by the immune system in response to an infection with a virus. These antibodies are capable of recognizing and binding to specific antigens on the surface of the virus, which helps to neutralize or destroy the virus and prevent its replication. Once produced, these antibodies can provide immunity against future infections with the same virus.

Viral antibodies are typically composed of four polypeptide chains - two heavy chains and two light chains - that are held together by disulfide bonds. The binding site for the antigen is located at the tip of the Y-shaped structure, formed by the variable regions of the heavy and light chains.

There are five classes of antibodies in humans: IgA, IgD, IgE, IgG, and IgM. Each class has a different function and is distributed differently throughout the body. For example, IgG is the most common type of antibody found in the bloodstream and provides long-term immunity against viruses, while IgA is found primarily in mucous membranes and helps to protect against respiratory and gastrointestinal infections.

In addition to their role in the immune response, viral antibodies can also be used as diagnostic tools to detect the presence of a specific virus in a patient's blood or other bodily fluids.

An antigen is any substance that can stimulate an immune response, particularly the production of antibodies. Viral antigens are antigens that are found on or produced by viruses. They can be proteins, glycoproteins, or carbohydrates present on the surface or inside the viral particle.

Viral antigens play a crucial role in the immune system's recognition and response to viral infections. When a virus infects a host cell, it may display its antigens on the surface of the infected cell. This allows the immune system to recognize and target the infected cells for destruction, thereby limiting the spread of the virus.

Viral antigens are also important targets for vaccines. Vaccines typically work by introducing a harmless form of a viral antigen to the body, which then stimulates the production of antibodies and memory T-cells that can recognize and respond quickly and effectively to future infections with the actual virus.

It's worth noting that different types of viruses have different antigens, and these antigens can vary between strains of the same virus. This is why there are often different vaccines available for different viral diseases, and why flu vaccines need to be updated every year to account for changes in the circulating influenza virus strains.

Virus cultivation, also known as virus isolation or viral culture, is a laboratory method used to propagate and detect viruses by introducing them to host cells and allowing them to replicate. This process helps in identifying the specific virus causing an infection and studying its characteristics, such as morphology, growth pattern, and sensitivity to antiviral agents.

The steps involved in virus cultivation typically include:

1. Collection of a clinical sample (e.g., throat swab, blood, sputum) from the patient.
2. Preparation of the sample by centrifugation or filtration to remove cellular debris and other contaminants.
3. Inoculation of the prepared sample into susceptible host cells, which can be primary cell cultures, continuous cell lines, or embryonated eggs, depending on the type of virus.
4. Incubation of the inoculated cells under appropriate conditions to allow viral replication.
5. Observation for cytopathic effects (CPE), which are changes in the host cells caused by viral replication, such as cell rounding, shrinkage, or lysis.
6. Confirmation of viral presence through additional tests, like immunofluorescence assays, polymerase chain reaction (PCR), or electron microscopy.

Virus cultivation is a valuable tool in diagnostic virology, vaccine development, and research on viral pathogenesis and host-virus interactions. However, it requires specialized equipment, trained personnel, and biosafety measures due to the potential infectivity of the viruses being cultured.

I'm sorry for any confusion, but "seasons" is not a term that has a medical definition. Seasons refer to the four divisions of the year (spring, summer, autumn or fall, and winter) based on the position of the earth in its orbit around the sun. If you have any questions related to health or medicine, I'd be happy to try to help answer those!

A disease outbreak is defined as the occurrence of cases of a disease in excess of what would normally be expected in a given time and place. It may affect a small and localized group or a large number of people spread over a wide area, even internationally. An outbreak may be caused by a new agent, a change in the agent's virulence or host susceptibility, or an increase in the size or density of the host population.

Outbreaks can have significant public health and economic impacts, and require prompt investigation and control measures to prevent further spread of the disease. The investigation typically involves identifying the source of the outbreak, determining the mode of transmission, and implementing measures to interrupt the chain of infection. This may include vaccination, isolation or quarantine, and education of the public about the risks and prevention strategies.

Examples of disease outbreaks include foodborne illnesses linked to contaminated food or water, respiratory infections spread through coughing and sneezing, and mosquito-borne diseases such as Zika virus and West Nile virus. Outbreaks can also occur in healthcare settings, such as hospitals and nursing homes, where vulnerable populations may be at increased risk of infection.

Viral proteins are the proteins that are encoded by the viral genome and are essential for the viral life cycle. These proteins can be structural or non-structural and play various roles in the virus's replication, infection, and assembly process. Structural proteins make up the physical structure of the virus, including the capsid (the protein shell that surrounds the viral genome) and any envelope proteins (that may be present on enveloped viruses). Non-structural proteins are involved in the replication of the viral genome and modulation of the host cell environment to favor viral replication. Overall, a thorough understanding of viral proteins is crucial for developing antiviral therapies and vaccines.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

I believe there might be a misunderstanding in your question. "Dogs" is not a medical term or condition. It is the common name for a domesticated carnivore of the family Canidae, specifically the genus Canis, which includes wolves, foxes, and other extant and extinct species of mammals. Dogs are often kept as pets and companions, and they have been bred in a wide variety of forms and sizes for different purposes, such as hunting, herding, guarding, assisting police and military forces, and providing companionship and emotional support.

If you meant to ask about a specific medical condition or term related to dogs, please provide more context so I can give you an accurate answer.

"Pyrans" is not a term commonly used in medical definitions. It is a chemical term that refers to a class of heterocyclic compounds containing a six-membered ring with one oxygen atom and five carbon atoms. The name "pyran" comes from the fact that it contains a pyroline unit (two double-bonded carbons) and a ketone group (a carbon double-bonded to an oxygen).

While pyrans are not directly related to medical definitions, some of their derivatives have been studied for potential medicinal applications. For example, certain pyran derivatives have shown anti-inflammatory, antiviral, and anticancer activities in laboratory experiments. However, more research is needed before these compounds can be considered as potential therapeutic agents.

Reassortant viruses are formed when two or more different strains of a virus infect the same cell and exchange genetic material, creating a new strain. This phenomenon is most commonly observed in segmented RNA viruses, such as influenza A and B viruses, where each strain may have a different combination of gene segments. When these reassortant viruses emerge, they can sometimes have altered properties, such as increased transmissibility or virulence, which can pose significant public health concerns. For example, pandemic influenza viruses often arise through the process of reassortment between human and animal strains.

Viral diseases are illnesses caused by the infection and replication of viruses in host organisms. These infectious agents are obligate parasites, meaning they rely on the cells of other living organisms to survive and reproduce. Viruses can infect various types of hosts, including animals, plants, and microorganisms, causing a wide range of diseases with varying symptoms and severity.

Once a virus enters a host cell, it takes over the cell's machinery to produce new viral particles, often leading to cell damage or death. The immune system recognizes the viral components as foreign and mounts an immune response to eliminate the infection. This response can result in inflammation, fever, and other symptoms associated with viral diseases.

Examples of well-known viral diseases include:

1. Influenza (flu) - caused by influenza A, B, or C viruses
2. Common cold - usually caused by rhinoviruses or coronaviruses
3. HIV/AIDS - caused by human immunodeficiency virus (HIV)
4. Measles - caused by measles morbillivirus
5. Hepatitis B and C - caused by hepatitis B virus (HBV) and hepatitis C virus (HCV), respectively
6. Herpes simplex - caused by herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2)
7. Chickenpox and shingles - both caused by varicella-zoster virus (VZV)
8. Rabies - caused by rabies lyssavirus
9. Ebola - caused by ebolaviruses
10. COVID-19 - caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Prevention and treatment strategies for viral diseases may include vaccination, antiviral medications, and supportive care to manage symptoms while the immune system fights off the infection.

Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. The virus is transmitted through contact with infected blood, semen, and other bodily fluids. It can also be passed from an infected mother to her baby at birth.

Acute hepatitis B infection lasts for a few weeks to several months and often causes no symptoms. However, some people may experience mild to severe flu-like symptoms, yellowing of the skin and eyes (jaundice), dark urine, and fatigue. Most adults with acute hepatitis B recover completely and develop lifelong immunity to the virus.

Chronic hepatitis B infection can lead to serious liver damage, including cirrhosis and liver cancer. People with chronic hepatitis B may experience long-term symptoms such as fatigue, joint pain, and depression. They are also at risk for developing liver failure and liver cancer.

Prevention measures include vaccination, safe sex practices, avoiding sharing needles or other drug injection equipment, and covering wounds and skin rashes. There is no specific treatment for acute hepatitis B, but chronic hepatitis B can be treated with antiviral medications to slow the progression of liver damage.

A cell line is a culture of cells that are grown in a laboratory for use in research. These cells are usually taken from a single cell or group of cells, and they are able to divide and grow continuously in the lab. Cell lines can come from many different sources, including animals, plants, and humans. They are often used in scientific research to study cellular processes, disease mechanisms, and to test new drugs or treatments. Some common types of human cell lines include HeLa cells (which come from a cancer patient named Henrietta Lacks), HEK293 cells (which come from embryonic kidney cells), and HUVEC cells (which come from umbilical vein endothelial cells). It is important to note that cell lines are not the same as primary cells, which are cells that are taken directly from a living organism and have not been grown in the lab.

RNA viruses are a type of virus that contain ribonucleic acid (RNA) as their genetic material, as opposed to deoxyribonucleic acid (DNA). RNA viruses replicate by using an enzyme called RNA-dependent RNA polymerase to transcribe and replicate their RNA genome.

There are several different groups of RNA viruses, including:

1. Negative-sense single-stranded RNA viruses: These viruses have a genome that is complementary to the mRNA and must undergo transcription to produce mRNA before translation can occur. Examples include influenza virus, measles virus, and rabies virus.
2. Positive-sense single-stranded RNA viruses: These viruses have a genome that can serve as mRNA and can be directly translated into protein after entry into the host cell. Examples include poliovirus, rhinoviruses, and coronaviruses.
3. Double-stranded RNA viruses: These viruses have a genome consisting of double-stranded RNA and use a complex replication strategy involving both transcription and reverse transcription. Examples include rotaviruses and reoviruses.

RNA viruses are known to cause a wide range of human diseases, ranging from the common cold to more severe illnesses such as hepatitis C, polio, and COVID-19. Due to their high mutation rates and ability to adapt quickly to new environments, RNA viruses can be difficult to control and treat with antiviral drugs or vaccines.

Nucleoproteins are complexes formed by the association of proteins with nucleic acids (DNA or RNA). These complexes play crucial roles in various biological processes, such as packaging and protecting genetic material, regulating gene expression, and replication and repair of DNA. In these complexes, proteins interact with nucleic acids through electrostatic, hydrogen bonding, and other non-covalent interactions, leading to the formation of stable structures that help maintain the integrity and function of the genetic material. Some well-known examples of nucleoproteins include histones, which are involved in DNA packaging in eukaryotic cells, and reverse transcriptase, an enzyme found in retroviruses that transcribes RNA into DNA.

Influenza Virus C is a type of influenza virus that causes respiratory illness in humans. It is one of the three types of influenza viruses, along with Influenza A and Influenza B, that are known to infect humans. However, Influenza Virus C is much less common than Influenza A and B and typically causes milder symptoms.

Influenza Virus C is an enveloped, negative-sense, single-stranded RNA virus that belongs to the family Orthomyxoviridae. It has a distinct antigenic structure from Influenza A and B viruses and is not typically associated with large outbreaks or epidemics.

Infection with Influenza Virus C can cause respiratory symptoms such as cough, sore throat, and fever. However, it is not known to cause severe illness or death in otherwise healthy individuals. Antiviral medications are generally not recommended for treatment of Influenza Virus C infections, but supportive care such as rest, hydration, and fever reduction can help alleviate symptoms.

It's worth noting that most people develop immunity to Influenza Virus C after infection, which provides protection against future infections with the same strain. However, new strains of Influenza Virus C can emerge over time, which may require updated vaccines to provide adequate protection.

A pandemic is a global outbreak of a disease that spreads easily from person to person across a large region, such as multiple continents or worldwide. It is declared by the World Health Organization (WHO) when the spread of a disease poses a significant threat to the global population due to its severity and transmissibility.

Pandemics typically occur when a new strain of virus emerges that has not been previously seen in humans, for which there is little or no pre-existing immunity. This makes it difficult to control the spread of the disease, as people do not have natural protection against it. Examples of pandemics include the 1918 Spanish flu pandemic and the more recent COVID-19 pandemic caused by the SARS-CoV-2 virus.

During a pandemic, healthcare systems can become overwhelmed, and there may be significant social and economic disruption as governments take measures to slow the spread of the disease, such as travel restrictions, quarantines, and lockdowns. Effective vaccines and treatments are critical in controlling the spread of pandemics and reducing their impact on public health.

The nasopharynx is the uppermost part of the pharynx (throat), which is located behind the nose. It is a muscular cavity that serves as a passageway for air and food. The nasopharynx extends from the base of the skull to the lower border of the soft palate, where it continues as the oropharynx. Its primary function is to allow air to flow into the respiratory system through the nostrils while also facilitating the drainage of mucus from the nose into the throat. The nasopharynx contains several important structures, including the adenoids and the opening of the Eustachian tubes, which connect the middle ear to the back of the nasopharynx.

Virology is the study of viruses, their classification, and their effects on living organisms. It involves the examination of viral genetic material, viral replication, how viruses cause disease, and the development of antiviral drugs and vaccines to treat or prevent virus infections. Virologists study various types of viruses that can infect animals, plants, and microorganisms, as well as understand their evolution and transmission patterns.

Viral genes refer to the genetic material present in viruses that contains the information necessary for their replication and the production of viral proteins. In DNA viruses, the genetic material is composed of double-stranded or single-stranded DNA, while in RNA viruses, it is composed of single-stranded or double-stranded RNA.

Viral genes can be classified into three categories: early, late, and structural. Early genes encode proteins involved in the replication of the viral genome, modulation of host cell processes, and regulation of viral gene expression. Late genes encode structural proteins that make up the viral capsid or envelope. Some viruses also have structural genes that are expressed throughout their replication cycle.

Understanding the genetic makeup of viruses is crucial for developing antiviral therapies and vaccines. By targeting specific viral genes, researchers can develop drugs that inhibit viral replication and reduce the severity of viral infections. Additionally, knowledge of viral gene sequences can inform the development of vaccines that stimulate an immune response to specific viral proteins.

Inactivated vaccines, also known as killed or non-live vaccines, are created by using a version of the virus or bacteria that has been grown in a laboratory and then killed or inactivated with chemicals, heat, or radiation. This process renders the organism unable to cause disease, but still capable of stimulating an immune response when introduced into the body.

Inactivated vaccines are generally considered safer than live attenuated vaccines since they cannot revert back to a virulent form and cause illness. However, they may require multiple doses or booster shots to maintain immunity because the immune response generated by inactivated vaccines is not as robust as that produced by live vaccines. Examples of inactivated vaccines include those for hepatitis A, rabies, and influenza (inactivated flu vaccine).

Phylogeny is the evolutionary history and relationship among biological entities, such as species or genes, based on their shared characteristics. In other words, it refers to the branching pattern of evolution that shows how various organisms have descended from a common ancestor over time. Phylogenetic analysis involves constructing a tree-like diagram called a phylogenetic tree, which depicts the inferred evolutionary relationships among organisms or genes based on molecular sequence data or other types of characters. This information is crucial for understanding the diversity and distribution of life on Earth, as well as for studying the emergence and spread of diseases.

Amantadine is an antiviral medication that is primarily used to prevent and treat certain types of influenza (flu). It works by stopping the virus from multiplying in your body. In addition to its antiviral properties, amantadine also has central nervous system (CNS) stimulant and dopaminergic effects, which make it useful in the treatment of Parkinson's disease and various movement disorders.

The medical definition of Amantadine is:

A synthetic symmetrical tricyclic amine used as an antiviral agent to treat and prevent influenza A infection and as an anti-parkinsonian drug to control extrapyramidal symptoms caused by neuroleptic agents. The antiviral effect may be due to interference with viral uncoating or replication. The anti-parkinsonian effect may be due to a combination of dopamine agonist and NMDA receptor antagonist properties. (Stedman's Medical Dictionary, 28th edition)

Please note that the use of Amantadine for various medical conditions should always be under the supervision of a healthcare professional, as they will consider potential benefits and risks and provide appropriate guidance.

Hepatitis B Surface Antigens (HBsAg) are proteins found on the surface of the Hepatitis B virus. They are present in the blood of individuals infected with the Hepatitis B virus and are used as a marker for the presence of a current Hepatitis B infection. The detection of HBsAg in the blood indicates that an individual is infectious and can transmit the virus to others. It is typically used in diagnostic tests to detect and diagnose Hepatitis B infections, monitor treatment response, and assess the risk of transmission.

Virus shedding refers to the release of virus particles by an infected individual, who can then transmit the virus to others through various means such as respiratory droplets, fecal matter, or bodily fluids. This occurs when the virus replicates inside the host's cells and is released into the surrounding environment, where it can infect other individuals. The duration of virus shedding varies depending on the specific virus and the individual's immune response. It's important to note that some individuals may shed viruses even before they show symptoms, making infection control measures such as hand hygiene, mask-wearing, and social distancing crucial in preventing the spread of infectious diseases.

Duck hepatitis B virus (DHBV) is not a medical definition related to human health, but it is a species of hepatitis B virus that primarily infects various species of ducks and other Anseriformes (waterfowl). It is closely related to the human hepatitis B virus (HBV), but it is not known to infect humans or other mammals.

DHBV, like HBV, is a DNA virus that targets the liver and can cause both acute and chronic infections. The virus is transmitted through the fecal-oral route and primarily affects young ducklings. Infection with DHBV can lead to liver damage and death in infected birds.

Researchers study DHBV as a model system for understanding HBV infection and pathogenesis, due to their similarities in viral structure, replication strategy, and host-virus interactions. However, it is important to note that DHBV is not a human health concern and does not pose a risk of infection to humans or other mammals.

'Influenza A Virus, H9N2 Subtype' is a type of influenza virus that causes respiratory illness in birds and occasionally in humans. It has been found to infect various animal species, including pigs, dogs, and horses. The H9N2 subtype has eight negative-sense RNA segments, encoding several proteins, such as hemagglutinin (H), neuraminidase (N), matrix protein (M), nucleoprotein (NP), nonstructural protein (NS), and three polymerase proteins (PA, PB1, and PB2).

The H9 hemagglutinin and N2 neuraminidase surface glycoproteins define the subtype of this influenza virus. The H9N2 viruses are known to have low pathogenicity in birds but can cause mild to moderate respiratory symptoms in humans, particularly those with occupational exposure to poultry or live bird markets.

H9N2 viruses have sporadically infected humans since their first identification in the 1960s and pose a pandemic threat due to their ability to reassort genetic material with other influenza A viruses, potentially creating new strains with increased transmissibility and pathogenicity for humans.

Viral matrix proteins are structural proteins that play a crucial role in the morphogenesis and life cycle of many viruses. They are often located between the viral envelope and the viral genome, serving as a scaffold for virus assembly and budding. These proteins also interact with other viral components, such as the viral genome, capsid proteins, and envelope proteins, to form an infectious virion. Additionally, matrix proteins can have regulatory functions, influencing viral transcription, replication, and host cell responses. The specific functions of viral matrix proteins vary among different virus families.

Vaccinia virus is a large, complex DNA virus that belongs to the Poxviridae family. It is the virus used in the production of the smallpox vaccine. The vaccinia virus is not identical to the variola virus, which causes smallpox, but it is closely related and provides cross-protection against smallpox infection.

The vaccinia virus has a unique replication cycle that occurs entirely in the cytoplasm of infected cells, rather than in the nucleus like many other DNA viruses. This allows the virus to evade host cell defenses and efficiently produce new virions. The virus causes the formation of pocks or lesions on the skin, which contain large numbers of virus particles that can be transmitted to others through close contact.

Vaccinia virus has also been used as a vector for the delivery of genes encoding therapeutic proteins, vaccines against other infectious diseases, and cancer therapies. However, the use of vaccinia virus as a vector is limited by its potential to cause adverse reactions in some individuals, particularly those with weakened immune systems or certain skin conditions.

Viral DNA refers to the genetic material present in viruses that consist of DNA as their core component. Deoxyribonucleic acid (DNA) is one of the two types of nucleic acids that are responsible for storing and transmitting genetic information in living organisms. Viruses are infectious agents much smaller than bacteria that can only replicate inside the cells of other organisms, called hosts.

Viral DNA can be double-stranded (dsDNA) or single-stranded (ssDNA), depending on the type of virus. Double-stranded DNA viruses have a genome made up of two complementary strands of DNA, while single-stranded DNA viruses contain only one strand of DNA.

Examples of dsDNA viruses include Adenoviruses, Herpesviruses, and Poxviruses, while ssDNA viruses include Parvoviruses and Circoviruses. Viral DNA plays a crucial role in the replication cycle of the virus, encoding for various proteins necessary for its multiplication and survival within the host cell.

Neutralization tests are a type of laboratory assay used in microbiology and immunology to measure the ability of a substance, such as an antibody or antitoxin, to neutralize the activity of a toxin or infectious agent. In these tests, the substance to be tested is mixed with a known quantity of the toxin or infectious agent, and the mixture is then incubated under controlled conditions. After incubation, the mixture is tested for residual toxicity or infectivity using a variety of methods, such as cell culture assays, animal models, or biochemical assays.

The neutralization titer is then calculated based on the highest dilution of the test substance that completely neutralizes the toxin or infectious agent. Neutralization tests are commonly used in the diagnosis and evaluation of immune responses to vaccines, as well as in the detection and quantification of toxins and other harmful substances.

Examples of neutralization tests include the serum neutralization test for measles antibodies, the plaque reduction neutralization test (PRNT) for dengue virus antibodies, and the cytotoxicity neutralization assay for botulinum neurotoxins.

Virus receptors are specific molecules (commonly proteins) on the surface of host cells that viruses bind to in order to enter and infect those cells. This interaction between the virus and its receptor is a critical step in the infection process. Different types of viruses have different receptor requirements, and identifying these receptors can provide important insights into the biology of the virus and potential targets for antiviral therapies.

Respiratory Syncytial Viruses (RSV) are a common type of virus that cause respiratory infections, particularly in young children and older adults. They are responsible for inflammation and narrowing of the small airways in the lungs, leading to breathing difficulties and other symptoms associated with bronchiolitis and pneumonia.

The term "syncytial" refers to the ability of these viruses to cause infected cells to merge and form large multinucleated cells called syncytia, which is a characteristic feature of RSV infections. The virus spreads through respiratory droplets when an infected person coughs or sneezes, and it can also survive on surfaces for several hours, making transmission easy.

RSV infections are most common during the winter months and can cause mild to severe symptoms depending on factors such as age, overall health, and underlying medical conditions. While RSV is typically associated with respiratory illnesses in children, it can also cause significant disease in older adults and immunocompromised individuals. Currently, there is no vaccine available for RSV, but antiviral medications and supportive care are used to manage severe infections.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Drug resistance, viral, refers to the ability of a virus to continue replicating in the presence of antiviral drugs that are designed to inhibit or stop its growth. This occurs when the virus mutates and changes its genetic makeup in such a way that the drug can no longer effectively bind to and inhibit the function of its target protein, allowing the virus to continue infecting host cells and causing disease.

Viral drug resistance can develop due to several factors, including:

1. Mutations in the viral genome that alter the structure or function of the drug's target protein.
2. Changes in the expression levels or location of the drug's target protein within the virus-infected cell.
3. Activation of alternative pathways that allow the virus to replicate despite the presence of the drug.
4. Increased efflux of the drug from the virus-infected cell, reducing its intracellular concentration and effectiveness.

Viral drug resistance is a significant concern in the treatment of viral infections such as HIV, hepatitis B and C, herpes simplex virus, and influenza. It can lead to reduced treatment efficacy, increased risk of treatment failure, and the need for more toxic or expensive drugs. Therefore, it is essential to monitor viral drug resistance during treatment and adjust therapy accordingly to ensure optimal outcomes.

'Influenza A Virus, H3N8 Subtype' is a type of influenza virus that causes respiratory illness in animals, particularly horses and dogs. It is one of the many subtypes of Influenza A viruses, which are classified based on two proteins found on the surface of the virus: hemagglutinin (H) and neuraminidase (N). The H3N8 subtype has hemagglutinin protein type 3 and neuraminidase protein type 8.

While H3N8 is not typically known to cause illness in humans, it can occasionally infect people who have close contact with infected animals. However, human-to-human transmission of this subtype is rare. It's important to note that influenza viruses are constantly changing and evolving, so the potential for new strains to emerge and pose a threat to human health cannot be ruled out.

Regular surveillance and monitoring of animal populations for influenza viruses, as well as ongoing research into their transmission dynamics and genetic changes, are crucial for early detection and response to potential pandemic threats.

"Influenza A Virus, H7N7 Subtype" is a type of influenza virus that causes respiratory illness in humans and animals. The "H" and "N" in the name refer to two proteins on the surface of the virus, hemagglutinin (H) and neuraminidase (N), respectively. In this subtype, the H7 protein is combined with the N7 protein.

H7N7 viruses are primarily avian influenza viruses, meaning they naturally infect birds. However, they can occasionally infect other animals, including humans, and have caused sporadic human infections and outbreaks, mainly in people who have close contact with infected birds or their droppings.

H7N7 infections in humans can range from mild to severe respiratory illness, and some cases have resulted in death. However, human-to-human transmission of H7N7 viruses is rare. Public health authorities closely monitor H7N7 and other avian influenza viruses due to their potential to cause a pandemic if they acquire the ability to transmit efficiently between humans.

Viral core proteins are the structural proteins that make up the viral capsid or protein shell, enclosing and protecting the viral genome. These proteins play a crucial role in the assembly of the virion, assist in the infection process by helping to deliver the viral genome into the host cell, and may also have functions in regulating viral replication. The specific composition and structure of viral core proteins vary among different types of viruses.

Sentinel surveillance is a type of public health surveillance that is used to monitor the occurrence and spread of specific diseases or health events in a defined population. It is called "sentinel" because it relies on a network of carefully selected healthcare providers, hospitals, or laboratories to report cases of the disease or event of interest.

The main goal of sentinel surveillance is to provide timely and accurate information about the incidence and trends of a particular health problem in order to inform public health action. This type of surveillance is often used when it is not feasible or practical to monitor an entire population, such as in the case of rare diseases or emerging infectious diseases.

Sentinel surveillance systems typically require well-defined criteria for case identification and reporting, as well as standardized data collection and analysis methods. They may also involve active monitoring and follow-up of cases to better understand the epidemiology of the disease or event. Overall, sentinel surveillance is an important tool for detecting and responding to public health threats in a timely and effective manner.

Guanidines are organic compounds that contain a guanidino group, which is a functional group with the formula -NH-C(=NH)-NH2. Guanidines can be found in various natural sources, including some animals, plants, and microorganisms. They also occur as byproducts of certain metabolic processes in the body.

In a medical context, guanidines are most commonly associated with the treatment of muscle weakness and neuromuscular disorders. The most well-known guanidine compound is probably guanidine hydrochloride, which has been used as a medication to treat conditions such as myasthenia gravis and Eaton-Lambert syndrome.

However, the use of guanidines as medications has declined in recent years due to their potential for toxicity and the development of safer and more effective treatments. Today, guanidines are mainly used in research settings to study various biological processes, including protein folding and aggregation, enzyme inhibition, and cell signaling.

Viral nonstructural proteins (NS) are viral proteins that are not part of the virion structure. They play various roles in the viral life cycle, such as replication of the viral genome, transcription, translation regulation, and modulation of the host cell environment to favor virus replication. These proteins are often produced in large quantities during infection and can manipulate or disrupt various cellular pathways to benefit the virus. They may also be involved in evasion of the host's immune response. The specific functions of viral nonstructural proteins vary depending on the type of virus.

Respiratory tract infections (RTIs) are infections that affect the respiratory system, which includes the nose, throat (pharynx), voice box (larynx), windpipe (trachea), bronchi, and lungs. These infections can be caused by viruses, bacteria, or, less commonly, fungi.

RTIs are classified into two categories based on their location: upper respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs). URTIs include infections of the nose, sinuses, throat, and larynx, such as the common cold, flu, laryngitis, and sinusitis. LRTIs involve the lower airways, including the bronchi and lungs, and can be more severe. Examples of LRTIs are pneumonia, bronchitis, and bronchiolitis.

Symptoms of RTIs depend on the location and cause of the infection but may include cough, congestion, runny nose, sore throat, difficulty breathing, wheezing, fever, fatigue, and chest pain. Treatment for RTIs varies depending on the severity and underlying cause of the infection. For viral infections, treatment typically involves supportive care to manage symptoms, while antibiotics may be prescribed for bacterial infections.

A virion is the complete, infectious form of a virus outside its host cell. It consists of the viral genome (DNA or RNA) enclosed within a protein coat called the capsid, which is often surrounded by a lipid membrane called the envelope. The envelope may contain viral proteins and glycoproteins that aid in attachment to and entry into host cells during infection. The term "virion" emphasizes the infectious nature of the virus particle, as opposed to non-infectious components like individual capsid proteins or naked viral genome.

Virus assembly, also known as virion assembly, is the final stage in the virus life cycle where individual viral components come together to form a complete viral particle or virion. This process typically involves the self-assembly of viral capsid proteins around the viral genome (DNA or RNA) and, in enveloped viruses, the acquisition of a lipid bilayer membrane containing viral glycoproteins. The specific mechanisms and regulation of virus assembly vary among different viral families, but it is often directed by interactions between viral structural proteins and genomic nucleic acid.

Attenuated vaccines consist of live microorganisms that have been weakened (attenuated) through various laboratory processes so they do not cause disease in the majority of recipients but still stimulate an immune response. The purpose of attenuation is to reduce the virulence or replication capacity of the pathogen while keeping it alive, allowing it to retain its antigenic properties and induce a strong and protective immune response.

Examples of attenuated vaccines include:

1. Sabin oral poliovirus vaccine (OPV): This vaccine uses live but weakened polioviruses to protect against all three strains of the disease-causing poliovirus. The weakened viruses replicate in the intestine and induce an immune response, which provides both humoral (antibody) and cell-mediated immunity.
2. Measles, mumps, and rubella (MMR) vaccine: This combination vaccine contains live attenuated measles, mumps, and rubella viruses. It is given to protect against these three diseases and prevent their spread in the population.
3. Varicella (chickenpox) vaccine: This vaccine uses a weakened form of the varicella-zoster virus, which causes chickenpox. By introducing this attenuated virus into the body, it stimulates an immune response that protects against future infection with the wild-type virus.
4. Yellow fever vaccine: This live attenuated vaccine is used to prevent yellow fever, a viral disease transmitted by mosquitoes in tropical and subtropical regions of Africa and South America. The vaccine contains a weakened form of the yellow fever virus that cannot cause the disease but still induces an immune response.
5. Bacillus Calmette-Guérin (BCG) vaccine: This live attenuated vaccine is used to protect against tuberculosis (TB). It contains a weakened strain of Mycobacterium bovis, which does not cause TB in humans but stimulates an immune response that provides some protection against the disease.

Attenuated vaccines are generally effective at inducing long-lasting immunity and can provide robust protection against targeted diseases. However, they may pose a risk for individuals with weakened immune systems, as the attenuated viruses or bacteria could potentially cause illness in these individuals. Therefore, it is essential to consider an individual's health status before administering live attenuated vaccines.

Parainfluenza Virus 1, Human (HPIV-1) is a type of respiratory virus that belongs to the family Paramyxoviridae and genus Respirovirus. It is one of the four serotypes of human parainfluenza viruses (HPIVs), which are important causes of acute respiratory infections in children, immunocompromised individuals, and the elderly.

HPIV-1 primarily infects the upper respiratory tract, causing symptoms such as cough, runny nose, sore throat, and fever. However, it can also cause lower respiratory tract infections, including bronchitis, bronchiolitis, and pneumonia, particularly in young children and infants.

HPIV-1 is transmitted through respiratory droplets or direct contact with infected individuals. The incubation period for HPIV-1 infection ranges from 2 to 7 days, after which symptoms can last for up to 10 days. There is no specific antiviral treatment available for HPIV-1 infections, and management typically involves supportive care such as hydration, fever reduction, and respiratory support if necessary.

Prevention measures include good hand hygiene, avoiding close contact with infected individuals, and practicing cough etiquette. Vaccines are not currently available for HPIV-1 infections, but research is ongoing to develop effective vaccines against these viruses.

Influenza A Virus: According to the World Health Organization (WHO), Influenza A virus is an orthomyxovirus that causes respiratory illness in humans and many other animal species. It can be found in birds, pigs, horses, and humans. The viral genome consists of eight single-stranded RNA segments enclosed within a lipid membrane derived from the host cell. Two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA), are used to classify Influenza A virus into subtypes based on antigenic properties. There are 18 different HA subtypes and 11 NA subtypes, but only H1N1, H2N2, and H3N2 have caused widespread human disease since the 1900s.

Influenza A viruses can be further divided into strains based on differences in their internal proteins. The most common cause of seasonal flu epidemics in humans is Influenza A (H3N2) and Influenza A (H1N1) pdm09, the latter of which caused the 2009 pandemic. Wild aquatic birds are the natural hosts for a large variety of influenza A viruses, and they are also responsible for the emergence of new subtypes.

These viruses can occasionally cause outbreaks in domestic poultry and, more rarely, in humans. Avian influenza A (H5N1), avian influenza A (H7N9), and avian influenza A (H1N1) are some examples of zoonotic influenza viruses that have caused severe disease and death in humans. However, sustained human-to-human transmission has not been observed with these subtypes, except for the 2009 H1N1 pandemic strain, which was a reassortant virus containing genes from both avian and swine influenza A viruses.

Vaccination is a simple, safe, and effective way to protect people against harmful diseases, before they come into contact with them. It uses your body's natural defenses to build protection to specific infections and makes your immune system stronger.

A vaccination usually contains a small, harmless piece of a virus or bacteria (or toxins produced by these germs) that has been made inactive or weakened so it won't cause the disease itself. This piece of the germ is known as an antigen. When the vaccine is introduced into the body, the immune system recognizes the antigen as foreign and produces antibodies to fight it.

If a person then comes into contact with the actual disease-causing germ, their immune system will recognize it and immediately produce antibodies to destroy it. The person is therefore protected against that disease. This is known as active immunity.

Vaccinations are important for both individual and public health. They prevent the spread of contagious diseases and protect vulnerable members of the population, such as young children, the elderly, and people with weakened immune systems who cannot be vaccinated or for whom vaccination is not effective.

'Cercopithecus aethiops' is the scientific name for the monkey species more commonly known as the green monkey. It belongs to the family Cercopithecidae and is native to western Africa. The green monkey is omnivorous, with a diet that includes fruits, nuts, seeds, insects, and small vertebrates. They are known for their distinctive greenish-brown fur and long tail. Green monkeys are also important animal models in biomedical research due to their susceptibility to certain diseases, such as SIV (simian immunodeficiency virus), which is closely related to HIV.

'Influenza A Virus, H2N2 Subtype' is a type of influenza virus that causes flu in humans and animals. It has the surface proteins hemagglutinin 2 (H) and neuraminidase 2 (N). This subtype was responsible for the Asian Flu pandemic in 1957-1958, which is estimated to have caused 1 to 4 million deaths worldwide. Since then, this specific H2N2 subtype has not circulated widely among humans. However, it still exists in animals such as birds and pigs, and there is a risk that it could evolve and infect humans again, which is why it is closely monitored by public health authorities.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

'Influenza A Virus, H7N9 Subtype' is a specific subtype of Influenza A virus that is known to primarily infect birds, but has also caused sporadic human infections in China since 2013. The 'H' and 'N' in the name refer to the proteins hemagglutinin (H) and neuraminidase (N), respectively, on the surface of the virus. In this subtype, the H7 and N9 proteins are found.

The H7N9 virus has caused serious illness in humans, with high fever, cough, and severe pneumonia being common symptoms. Some cases have resulted in death, particularly among those with underlying health conditions or weakened immune systems. The virus is not currently known to transmit efficiently from person to person, but there is concern that it could mutate and acquire the ability to spread more easily between humans, which could potentially lead to a pandemic.

It's important to note that seasonal flu vaccines do not provide protection against H7N9 virus, as it is antigenically distinct from seasonal influenza viruses. However, research and development efforts are ongoing to create a vaccine specifically for this subtype.

'Influenza A Virus, H5N2 Subtype' is a type of influenza virus that primarily infects birds, but has caused sporadic infections in humans who have had close contact with infected poultry or contaminated environments. The 'H5N2' refers to the specific subtype of the hemagglutinin (H) and neuraminidase (N) proteins found on the surface of the virus.

The H5N2 subtype has caused significant outbreaks in poultry populations, leading to substantial economic losses for the farming industry. While human infections with this subtype are rare, they can cause severe respiratory illness and have the potential to cause a pandemic if the virus were to acquire the ability to transmit efficiently from person to person.

It is important to note that seasonal influenza vaccines do not provide protection against H5N2 or other non-seasonal influenza viruses, highlighting the need for ongoing surveillance and research into new vaccine candidates.

A chick embryo refers to the developing organism that arises from a fertilized chicken egg. It is often used as a model system in biological research, particularly during the stages of development when many of its organs and systems are forming and can be easily observed and manipulated. The study of chick embryos has contributed significantly to our understanding of various aspects of developmental biology, including gastrulation, neurulation, organogenesis, and pattern formation. Researchers may use various techniques to observe and manipulate the chick embryo, such as surgical alterations, cell labeling, and exposure to drugs or other agents.

A viral plaque assay is a laboratory technique used to measure the infectivity and concentration of viruses in a sample. This method involves infecting a monolayer of cells (usually in a petri dish or multi-well plate) with a known volume of a virus-containing sample, followed by overlaying the cells with a nutrient-agar medium to restrict viral spread and enable individual plaques to form.

After an incubation period that allows for viral replication and cell death, the cells are stained, and clear areas or "plaques" become visible in the monolayer. Each plaque represents a localized region of infected and lysed cells, caused by the progeny of a single infectious virus particle. The number of plaques is then counted, and the viral titer (infectious units per milliliter or PFU/mL) is calculated based on the dilution factor and volume of the original inoculum.

Viral plaque assays are essential for determining viral titers, assessing virus-host interactions, evaluating antiviral agents, and studying viral pathogenesis.

Parainfluenza Virus 3, Human (HPIV-3) is an enveloped, single-stranded RNA virus that belongs to the family Paramyxoviridae and genus Respirovirus. It is one of the four serotypes of human parainfluenza viruses (HPIVs), which are important causes of acute respiratory tract infections in infants, young children, and immunocompromised individuals.

HPIV-3 primarily infects the upper and lower respiratory tract, causing a wide range of clinical manifestations, from mild to severe respiratory illnesses. The incubation period for HPIV-3 infection is typically 3-7 days. In infants and young children, HPIV-3 can cause croup (laryngotracheobronchitis), bronchiolitis, and pneumonia, while in adults, it usually results in mild upper respiratory tract infections, such as the common cold.

The virus is transmitted through direct contact with infected respiratory secretions or contaminated surfaces, and infection can occur throughout the year but tends to peak during fall and winter months. Currently, there are no approved vaccines for HPIV-3; treatment is primarily supportive and focuses on managing symptoms and complications.

Sialic acids are a family of nine-carbon sugars that are commonly found on the outermost surface of many cell types, particularly on the glycoconjugates of mucins in various secretions and on the glycoproteins and glycolipids of cell membranes. They play important roles in a variety of biological processes, including cell recognition, immune response, and viral and bacterial infectivity. Sialic acids can exist in different forms, with N-acetylneuraminic acid being the most common one in humans.

DNA Sequence Analysis is the systematic determination of the order of nucleotides in a DNA molecule. It is a critical component of modern molecular biology, genetics, and genetic engineering. The process involves determining the exact order of the four nucleotide bases - adenine (A), guanine (G), cytosine (C), and thymine (T) - in a DNA molecule or fragment. This information is used in various applications such as identifying gene mutations, studying evolutionary relationships, developing molecular markers for breeding, and diagnosing genetic diseases.

The process of DNA Sequence Analysis typically involves several steps, including DNA extraction, PCR amplification (if necessary), purification, sequencing reaction, and electrophoresis. The resulting data is then analyzed using specialized software to determine the exact sequence of nucleotides.

In recent years, high-throughput DNA sequencing technologies have revolutionized the field of genomics, enabling the rapid and cost-effective sequencing of entire genomes. This has led to an explosion of genomic data and new insights into the genetic basis of many diseases and traits.

Hepatitis B core antigen (HBcAg) is a protein found in the core of the hepatitis B virus (HBV). It is present during active replication of the virus and plays a crucial role in the formation of the viral capsid or core. The antibodies produced against HBcAg (anti-HBc) can be detected in the blood, which serves as a marker for current or past HBV infection. It is important to note that HBcAg itself is not detectable in the blood because it is confined within the viral particle. However, during the serological testing of hepatitis B, the detection of anti-HBc IgM indicates a recent acute infection, while the presence of anti-HBc IgG suggests either a past resolved infection or an ongoing chronic infection.

Cross reactions, in the context of medical diagnostics and immunology, refer to a situation where an antibody or a immune response directed against one antigen also reacts with a different antigen due to similarities in their molecular structure. This can occur in allergy testing, where a person who is allergic to a particular substance may have a positive test result for a different but related substance because of cross-reactivity between them. For example, some individuals who are allergic to birch pollen may also have symptoms when eating certain fruits, such as apples, due to cross-reactive proteins present in both.

Hemagglutinins are proteins found on the surface of some viruses, including influenza viruses. They have the ability to bind to specific receptors on the surface of red blood cells, causing them to clump together (a process known as hemagglutination). This property is what allows certain viruses to infect host cells and cause disease. Hemagglutinins play a crucial role in the infection process of influenza viruses, as they facilitate the virus's entry into host cells by binding to sialic acid receptors on the surface of respiratory epithelial cells. There are 18 different subtypes of hemagglutinin (H1-H18) found in various influenza A viruses, and they are a major target of the immune response to influenza infection. Vaccines against influenza contain hemagglutinins from the specific strains of virus that are predicted to be most prevalent in a given season, and induce immunity by stimulating the production of antibodies that can neutralize the virus.

I am not aware of a medical definition for the term "birds." Birds are a group of warm-blooded vertebrates constituting the class Aves, characterized by feathers, toothless beaked jaws, the laying of hard-shelled eggs, and lightweight but strong skeletons. Some birds, such as pigeons and chickens, have been used in medical research, but the term "birds" itself does not have a specific medical definition.

Chronic Hepatitis B is a persistent infection of the liver caused by the hepatitis B virus (HBV), which can lead to chronic inflammation and scarring of the liver over time. It is defined as the presence of hepatitis B surface antigen (HBsAg) in the blood for more than six months.

The infection can be asymptomatic or may cause nonspecific symptoms such as fatigue, loss of appetite, nausea, and joint pain. A small percentage of people with chronic HBV infection may develop serious complications, including cirrhosis, liver failure, and liver cancer. Treatment options for chronic hepatitis B include antiviral medications that can help to suppress the virus and reduce the risk of liver damage. Vaccination is available to prevent hepatitis B infection.

A ferret is a domesticated mammal that belongs to the weasel family, Mustelidae. The scientific name for the common ferret is Mustela putorius furo. Ferrets are native to Europe and have been kept as pets for thousands of years due to their playful and curious nature. They are small animals, typically measuring between 13-20 inches in length, including their tail, and weighing between 1.5-4 pounds.

Ferrets have a slender body with short legs, a long neck, and a pointed snout. They have a thick coat of fur that can vary in color from white to black, with many different patterns in between. Ferrets are known for their high level of activity and intelligence, and they require regular exercise and mental stimulation to stay healthy and happy.

Ferrets are obligate carnivores, which means that they require a diet that is high in protein and low in carbohydrates. They have a unique digestive system that allows them to absorb nutrients efficiently from their food, but it also means that they are prone to certain health problems if they do not receive proper nutrition.

Ferrets are social animals and typically live in groups. They communicate with each other using a variety of vocalizations, including barks, chirps, and purrs. Ferrets can be trained to use a litter box and can learn to perform simple tricks. With proper care and attention, ferrets can make loving and entertaining pets.

RNA-dependent RNA polymerase, also known as RNA replicase, is an enzyme that catalyzes the production of RNA from an RNA template. It plays a crucial role in the replication of certain viruses, such as positive-strand RNA viruses and retroviruses, which use RNA as their genetic material. The enzyme uses the existing RNA strand as a template to create a new complementary RNA strand, effectively replicating the viral genome. This process is essential for the propagation of these viruses within host cells and is a target for antiviral therapies.

Simian Virus 40 (SV40) is a polyomavirus that is found in both monkeys and humans. It is a DNA virus that has been extensively studied in laboratory settings due to its ability to transform cells and cause tumors in animals. In fact, SV40 was discovered as a contaminant of poliovirus vaccines that were prepared using rhesus monkey kidney cells in the 1950s and 1960s.

SV40 is not typically associated with human disease, but there has been some concern that exposure to the virus through contaminated vaccines or other means could increase the risk of certain types of cancer, such as mesothelioma and brain tumors. However, most studies have failed to find a consistent link between SV40 infection and cancer in humans.

The medical community generally agrees that SV40 is not a significant public health threat, but researchers continue to study the virus to better understand its biology and potential impact on human health.

Defective viruses are viruses that have lost the ability to complete a full replication cycle and produce progeny virions independently. These viruses require the assistance of a helper virus, which provides the necessary functions for replication. Defective viruses can arise due to mutations, deletions, or other genetic changes that result in the loss of essential genes. They are often non-infectious and cannot cause disease on their own, but they may interfere with the replication of the helper virus and modulate the course of infection. Defective viruses can be found in various types of viruses, including retroviruses, bacteriophages, and DNA viruses.

A virus is a small infectious agent that replicates inside the living cells of an organism. It is not considered to be a living organism itself, as it lacks the necessary components to independently maintain its own metabolic functions. Viruses are typically composed of genetic material, either DNA or RNA, surrounded by a protein coat called a capsid. Some viruses also have an outer lipid membrane known as an envelope.

Viruses can infect all types of organisms, from animals and plants to bacteria and archaea. They cause various diseases by invading the host cell, hijacking its machinery, and using it to produce numerous copies of themselves, which can then infect other cells. The resulting infection and the immune response it triggers can lead to a range of symptoms, depending on the virus and the host organism.

Viruses are transmitted through various means, such as respiratory droplets, bodily fluids, contaminated food or water, and vectors like insects. Prevention methods include vaccination, practicing good hygiene, using personal protective equipment, and implementing public health measures to control their spread.

Parainfluenza Virus 2, Human (HPIV-2) is a type of respiratory virus that belongs to the family Paramyxoviridae and genus Respirovirus. It is one of the four serotypes of human parainfluenza viruses (HPIVs), which also include HPIV-1, HPIV-3, and HPIV-4.

HPIV-2 primarily infects the upper respiratory tract and causes mild to moderate symptoms similar to those caused by other respiratory viruses. The infection can lead to inflammation of the nose, throat, and voice box (larynx), resulting in a runny nose, sore throat, cough, and hoarseness. In some cases, HPIV-2 can also cause croup, a condition characterized by a barking cough and stridor (high-pitched breathing sounds) due to inflammation of the upper airways.

HPIV-2 is highly contagious and spreads through respiratory droplets produced when an infected person talks, coughs, or sneezes. The virus can also be transmitted by touching contaminated surfaces and then touching the mouth, nose, or eyes. HPIV-2 infections are most common in infants and young children, but people of all ages can become infected.

There is no specific treatment for HPIV-2 infections, and management typically involves supportive care to alleviate symptoms. Preventive measures include good hygiene practices, such as frequent handwashing, covering the mouth and nose when coughing or sneezing, and avoiding close contact with sick individuals. Vaccines are not available for HPIV-2 infections, but research is ongoing to develop effective vaccines against these viruses.

Influenza Virus B is one of the two primary types of influenza viruses that cause seasonal flu in humans, with Influenza A being the other.

Influenza Virus B primarily infects humans and is generally associated with less severe illness compared to Influenza A. However, it can still cause significant respiratory disease, hospitalizations, and deaths, particularly among high-risk populations such as young children, older adults, pregnant women, and people with certain underlying medical conditions.

Influenza Virus B has only one known host - humans, while Influenza A can infect a variety of animals, including birds, pigs, and horses, making it more prone to mutations and the emergence of new strains.

Like Influenza A, Influenza Virus B also undergoes genetic changes over time, leading to the need for regular updates to the seasonal flu vaccine to ensure that it provides protection against the circulating strains.

DNA viruses are a type of virus that contain DNA (deoxyribonucleic acid) as their genetic material. These viruses replicate by using the host cell's machinery to synthesize new viral components, which are then assembled into new viruses and released from the host cell.

DNA viruses can be further classified based on the structure of their genomes and the way they replicate. For example, double-stranded DNA (dsDNA) viruses have a genome made up of two strands of DNA, while single-stranded DNA (ssDNA) viruses have a genome made up of a single strand of DNA.

Examples of DNA viruses include herpes simplex virus, varicella-zoster virus, human papillomavirus, and adenoviruses. Some DNA viruses are associated with specific diseases, such as cancer (e.g., human papillomavirus) or neurological disorders (e.g., herpes simplex virus).

It's important to note that while DNA viruses contain DNA as their genetic material, RNA viruses contain RNA (ribonucleic acid) as their genetic material. Both DNA and RNA viruses can cause a wide range of diseases in humans, animals, and plants.

'Influenza A Virus, H1N2 Subtype' is a type of influenza virus that causes respiratory illness in humans and animals. The 'H' and 'N' in the name refer to two proteins on the surface of the virus, hemagglutinin (H) and neuraminidase (N), respectively. In this subtype, the specific forms are H1 and N2.

Influenza A viruses are divided into subtypes based on these surface proteins, and H1N2 is one of several subtypes that can infect humans. The H1N2 virus is known to have circulated in human populations since at least 2001, and it is thought to arise through the reassortment of genes from other influenza A viruses.

Like other influenza viruses, H1N2 can cause a range of symptoms including fever, cough, sore throat, runny or stuffy nose, muscle or body aches, headaches, and fatigue. In some cases, it can lead to more severe illnesses such as pneumonia and bronchitis, particularly in people with weakened immune systems, chronic medical conditions, or the elderly.

It is important to note that influenza viruses are constantly changing, and new subtypes and strains can emerge over time. This is why annual flu vaccinations are recommended to help protect against the most common circulating strains of the virus.

A plant virus is not defined in medical terms, as viruses are typically considered within the context of living organisms and plants are not classified as such. However, I can provide a general virology definition for you:

Plant viruses are small infectious agents that consist of nucleic acid (DNA or RNA) enclosed in a protein coat. They infect various plant species, causing a wide range of symptoms and diseases, which can result in significant economic losses in agriculture and horticulture. Plant viruses lack the ability to replicate outside a host cell, and they rely on the host's metabolic machinery for their reproduction. They can be transmitted through various means, such as insect vectors, seeds, or mechanical contact.

Hepatitis B e antigen (HBeAg) is a protein produced by the hepatitis B virus (HBV) during its replication process. It can be found in the blood of individuals infected with HBV. The presence of HBeAg generally indicates that the virus is actively replicating in the liver and that the individual has high levels of viral load.

HBeAg is a serological marker used to assess the severity and activity of HBV infection, as well as the response to antiviral treatment. In particular, the disappearance of HBeAg from the blood (known as seroconversion) is often associated with a decrease in viral replication and an improvement in liver disease. However, the presence of HBeAg does not necessarily mean that the individual will develop symptoms or liver damage, as some people can remain asymptomatic carriers of the virus for many years.

It's important to note that not all HBV strains produce HBeAg, and some mutant strains may not produce detectable levels of this antigen even when the virus is actively replicating. Therefore, additional tests may be needed to confirm the presence or absence of HBV infection in these cases.

Antigenic variation is a mechanism used by some microorganisms, such as bacteria and viruses, to evade the immune system and establish persistent infections. This occurs when these pathogens change or modify their surface antigens, which are molecules that can be recognized by the host's immune system and trigger an immune response.

The changes in the surface antigens can occur due to various mechanisms, such as gene mutation, gene rearrangement, or gene transfer. These changes can result in the production of new variants of the microorganism that are different enough from the original strain to avoid recognition by the host's immune system.

Antigenic variation is a significant challenge in developing effective vaccines against certain infectious diseases, such as malaria and influenza, because the constantly changing surface antigens make it difficult for the immune system to mount an effective response. Therefore, researchers are working on developing vaccines that target conserved regions of the microorganism that do not undergo antigenic variation or using a combination of antigens to increase the likelihood of recognition by the immune system.

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a laboratory technique used in molecular biology to amplify and detect specific DNA sequences. This technique is particularly useful for the detection and quantification of RNA viruses, as well as for the analysis of gene expression.

The process involves two main steps: reverse transcription and polymerase chain reaction (PCR). In the first step, reverse transcriptase enzyme is used to convert RNA into complementary DNA (cDNA) by reading the template provided by the RNA molecule. This cDNA then serves as a template for the PCR amplification step.

In the second step, the PCR reaction uses two primers that flank the target DNA sequence and a thermostable polymerase enzyme to repeatedly copy the targeted cDNA sequence. The reaction mixture is heated and cooled in cycles, allowing the primers to anneal to the template, and the polymerase to extend the new strand. This results in exponential amplification of the target DNA sequence, making it possible to detect even small amounts of RNA or cDNA.

RT-PCR is a sensitive and specific technique that has many applications in medical research and diagnostics, including the detection of viruses such as HIV, hepatitis C virus, and SARS-CoV-2 (the virus that causes COVID-19). It can also be used to study gene expression, identify genetic mutations, and diagnose genetic disorders.

Population surveillance in a public health and medical context refers to the ongoing, systematic collection, analysis, interpretation, and dissemination of health-related data for a defined population over time. It aims to monitor the health status, identify emerging health threats or trends, and evaluate the impact of interventions within that population. This information is used to inform public health policy, prioritize healthcare resources, and guide disease prevention and control efforts. Population surveillance can involve various data sources, such as vital records, disease registries, surveys, and electronic health records.

Hepatitis B antibodies are proteins produced by the immune system in response to the presence of the Hepatitis B virus. There are two main types of Hepatitis B antibodies:

1. Hepatitis B surface antibody (anti-HBs): This is produced when a person has recovered from a Hepatitis B infection or has been successfully vaccinated against the virus. The presence of anti-HBs indicates immunity to Hepatitis B.
2. Hepatitis B core antibody (anti-HBC): This is produced during a Hepatitis B infection and remains present for life, even after the infection has been cleared. However, the presence of anti-HBC alone does not indicate immunity to Hepatitis B, as it can also be present in people who have a chronic Hepatitis B infection.

It's important to note that testing for Hepatitis B antibodies is typically done through blood tests and can help determine whether a person has been infected with the virus, has recovered from an infection, or has been vaccinated against it.

Polymerase Chain Reaction (PCR) is a laboratory technique used to amplify specific regions of DNA. It enables the production of thousands to millions of copies of a particular DNA sequence in a rapid and efficient manner, making it an essential tool in various fields such as molecular biology, medical diagnostics, forensic science, and research.

The PCR process involves repeated cycles of heating and cooling to separate the DNA strands, allow primers (short sequences of single-stranded DNA) to attach to the target regions, and extend these primers using an enzyme called Taq polymerase, resulting in the exponential amplification of the desired DNA segment.

In a medical context, PCR is often used for detecting and quantifying specific pathogens (viruses, bacteria, fungi, or parasites) in clinical samples, identifying genetic mutations or polymorphisms associated with diseases, monitoring disease progression, and evaluating treatment effectiveness.

Sindbis virus is an alphavirus that belongs to the Togaviridae family. It's named after the location where it was first isolated, in Sindbis, Egypt, in 1952. This virus is primarily transmitted by mosquitoes and can infect a wide range of animals, including birds and humans. In humans, Sindbis virus infection often causes a mild flu-like illness characterized by fever, rash, and joint pain. However, some people may develop more severe symptoms, such as neurological disorders, although this is relatively rare. There is no specific treatment for Sindbis virus infection, and management typically involves supportive care to alleviate symptoms.

Nasal mucosa refers to the mucous membrane that lines the nasal cavity. It is a delicate, moist, and specialized tissue that contains various types of cells including epithelial cells, goblet cells, and glands. The primary function of the nasal mucosa is to warm, humidify, and filter incoming air before it reaches the lungs.

The nasal mucosa produces mucus, which traps dust, allergens, and microorganisms, preventing them from entering the respiratory system. The cilia, tiny hair-like structures on the surface of the epithelial cells, help move the mucus towards the back of the throat, where it can be swallowed or expelled.

The nasal mucosa also contains a rich supply of blood vessels and immune cells that help protect against infections and inflammation. It plays an essential role in the body's defense system by producing antibodies, secreting antimicrobial substances, and initiating local immune responses.

Measles virus is a single-stranded, negative-sense RNA virus belonging to the genus Morbillivirus in the family Paramyxoviridae. It is the causative agent of measles, a highly contagious infectious disease characterized by fever, cough, runny nose, and a red, blotchy rash. The virus primarily infects the respiratory tract and then spreads throughout the body via the bloodstream.

The genome of the measles virus is approximately 16 kilobases in length and encodes for eight proteins: nucleocapsid (N), phosphoprotein (P), matrix protein (M), fusion protein (F), hemagglutinin (H), large protein (L), and two non-structural proteins, V and C. The H protein is responsible for binding to the host cell receptor CD150 (SLAM) and mediating viral entry, while the F protein facilitates fusion of the viral and host cell membranes.

Measles virus is transmitted through respiratory droplets and direct contact with infected individuals. The virus can remain airborne for up to two hours in a closed space, making it highly contagious. Measles is preventable through vaccination, which has led to significant reductions in the incidence of the disease worldwide.

Nucleocapsid proteins are structural proteins that are associated with the viral genome in many viruses. They play a crucial role in the formation and stability of the viral particle, also known as the virion. In particular, nucleocapsid proteins bind to the viral RNA or DNA genome and help to protect it from degradation by host cell enzymes. They also participate in the assembly and disassembly of the virion during the viral replication cycle.

In some viruses, such as coronaviruses, the nucleocapsid protein is also involved in regulating the transcription and replication of the viral genome. The nucleocapsid protein of SARS-CoV-2, for example, has been shown to interact with host cell proteins that are involved in the regulation of gene expression, which may contribute to the virus's ability to manipulate the host cell environment and evade the immune response.

Overall, nucleocapsid proteins are important components of many viruses and are often targeted by antiviral therapies due to their essential role in the viral replication cycle.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Genetic variation refers to the differences in DNA sequences among individuals and populations. These variations can result from mutations, genetic recombination, or gene flow between populations. Genetic variation is essential for evolution by providing the raw material upon which natural selection acts. It can occur within a single gene, between different genes, or at larger scales, such as differences in the number of chromosomes or entire sets of chromosomes. The study of genetic variation is crucial in understanding the genetic basis of diseases and traits, as well as the evolutionary history and relationships among species.

An epitope is a specific region on the surface of an antigen (a molecule that can trigger an immune response) that is recognized by an antibody, B-cell receptor, or T-cell receptor. It is also commonly referred to as an antigenic determinant. Epitopes are typically composed of linear amino acid sequences or conformational structures made up of discontinuous amino acids in the antigen. They play a crucial role in the immune system's ability to differentiate between self and non-self molecules, leading to the targeted destruction of foreign substances like viruses and bacteria. Understanding epitopes is essential for developing vaccines, diagnostic tests, and immunotherapies.

Sensitivity and specificity are statistical measures used to describe the performance of a diagnostic test or screening tool in identifying true positive and true negative results.

* Sensitivity refers to the proportion of people who have a particular condition (true positives) who are correctly identified by the test. It is also known as the "true positive rate" or "recall." A highly sensitive test will identify most or all of the people with the condition, but may also produce more false positives.
* Specificity refers to the proportion of people who do not have a particular condition (true negatives) who are correctly identified by the test. It is also known as the "true negative rate." A highly specific test will identify most or all of the people without the condition, but may also produce more false negatives.

In medical testing, both sensitivity and specificity are important considerations when evaluating a diagnostic test. High sensitivity is desirable for screening tests that aim to identify as many cases of a condition as possible, while high specificity is desirable for confirmatory tests that aim to rule out the condition in people who do not have it.

It's worth noting that sensitivity and specificity are often influenced by factors such as the prevalence of the condition in the population being tested, the threshold used to define a positive result, and the reliability and validity of the test itself. Therefore, it's important to consider these factors when interpreting the results of a diagnostic test.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Genetic recombination is the process by which genetic material is exchanged between two similar or identical molecules of DNA during meiosis, resulting in new combinations of genes on each chromosome. This exchange occurs during crossover, where segments of DNA are swapped between non-sister homologous chromatids, creating genetic diversity among the offspring. It is a crucial mechanism for generating genetic variability and facilitating evolutionary change within populations. Additionally, recombination also plays an essential role in DNA repair processes through mechanisms such as homologous recombinational repair (HRR) and non-homologous end joining (NHEJ).

An amino acid substitution is a type of mutation in which one amino acid in a protein is replaced by another. This occurs when there is a change in the DNA sequence that codes for a particular amino acid in a protein. The genetic code is redundant, meaning that most amino acids are encoded by more than one codon (a sequence of three nucleotides). As a result, a single base pair change in the DNA sequence may not necessarily lead to an amino acid substitution. However, if a change does occur, it can have a variety of effects on the protein's structure and function, depending on the nature of the substituted amino acids. Some substitutions may be harmless, while others may alter the protein's activity or stability, leading to disease.

"Ducks" is not a medical term. It is a common name used to refer to a group of birds that belong to the family Anatidae, which also includes swans and geese. Some ducks are hunted for their meat, feathers, or down, but they do not have any specific medical relevance. If you have any questions about a specific medical term or concept, I would be happy to help if you could provide more information!

Rabies is a viral disease that affects the nervous system of mammals, including humans. It's caused by the rabies virus (RV), which belongs to the family Rhabdoviridae and genus Lyssavirus. The virus has a bullet-shaped appearance under an electron microscope and is encased in a lipid envelope.

The rabies virus primarily spreads through the saliva of infected animals, usually via bites. Once inside the body, it travels along nerve fibers to the brain, where it multiplies rapidly and causes inflammation (encephalitis). The infection can lead to symptoms such as anxiety, confusion, hallucinations, seizures, paralysis, coma, and ultimately death if left untreated.

Rabies is almost always fatal once symptoms appear, but prompt post-exposure prophylaxis (PEP), which includes vaccination and sometimes rabies immunoglobulin, can prevent the disease from developing when administered after an exposure to a potentially rabid animal. Pre-exposure vaccination is also recommended for individuals at high risk of exposure, such as veterinarians and travelers visiting rabies-endemic areas.

Complement fixation tests are a type of laboratory test used in immunology and serology to detect the presence of antibodies in a patient's serum. These tests are based on the principle of complement activation, which is a part of the immune response. The complement system consists of a group of proteins that work together to help eliminate pathogens from the body.

In a complement fixation test, the patient's serum is mixed with a known antigen and complement proteins. If the patient has antibodies against the antigen, they will bind to it and activate the complement system. This results in the consumption or "fixation" of the complement proteins, which are no longer available to participate in a secondary reaction.

A second step involves adding a fresh source of complement proteins and a dye-labeled antibody that recognizes a specific component of the complement system. If complement was fixed during the first step, it will not be available for this secondary reaction, and the dye-labeled antibody will remain unbound. Conversely, if no antibodies were present in the patient's serum, the complement proteins would still be available for the second reaction, leading to the binding of the dye-labeled antibody.

The mixture is then examined under a microscope or using a spectrophotometer to determine whether the dye-labeled antibody has bound. If it has not, this indicates that the patient's serum contains antibodies specific to the antigen used in the test, and a positive result is recorded.

Complement fixation tests have been widely used for the diagnosis of various infectious diseases, such as syphilis, measles, and influenza. However, they have largely been replaced by more modern serological techniques, like enzyme-linked immunosorbent assays (ELISAs) and nucleic acid amplification tests (NAATs), due to their increased sensitivity, specificity, and ease of use.

Species specificity is a term used in the field of biology, including medicine, to refer to the characteristic of a biological entity (such as a virus, bacterium, or other microorganism) that allows it to interact exclusively or preferentially with a particular species. This means that the biological entity has a strong affinity for, or is only able to infect, a specific host species.

For example, HIV is specifically adapted to infect human cells and does not typically infect other animal species. Similarly, some bacterial toxins are species-specific and can only affect certain types of animals or humans. This concept is important in understanding the transmission dynamics and host range of various pathogens, as well as in developing targeted therapies and vaccines.

Vero cells are a line of cultured kidney epithelial cells that were isolated from an African green monkey (Cercopithecus aethiops) in the 1960s. They are named after the location where they were initially developed, the Vervet Research Institute in Japan.

Vero cells have the ability to divide indefinitely under certain laboratory conditions and are often used in scientific research, including virology, as a host cell for viruses to replicate. This allows researchers to study the characteristics of various viruses, such as their growth patterns and interactions with host cells. Vero cells are also used in the production of some vaccines, including those for rabies, polio, and Japanese encephalitis.

It is important to note that while Vero cells have been widely used in research and vaccine production, they can still have variations between different cell lines due to factors like passage number or culture conditions. Therefore, it's essential to specify the exact source and condition of Vero cells when reporting experimental results.

Viral activation, also known as viral reactivation or virus reactivation, refers to the process in which a latent or dormant virus becomes active and starts to replicate within a host cell. This can occur when the immune system is weakened or compromised, allowing the virus to evade the body's natural defenses and cause disease.

In some cases, viral activation can be triggered by certain environmental factors, such as stress, exposure to UV light, or infection with another virus. Once activated, the virus can cause symptoms similar to those seen during the initial infection, or it may lead to new symptoms depending on the specific virus and the host's immune response.

Examples of viruses that can remain dormant in the body and be reactivated include herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), and Epstein-Barr virus (EBV). It is important to note that not all viruses can be reactivated, and some may remain dormant in the body indefinitely without causing any harm.

Cyclopentanes are a class of hydrocarbons that contain a cycloalkane ring of five carbon atoms. The chemical formula for cyclopentane is C5H10. It is a volatile, flammable liquid that is used as a solvent and in the production of polymers. Cyclopentanes are also found naturally in petroleum and coal tar.

Cyclopentanes have a unique structure in which the carbon atoms are arranged in a pentagonal shape, with each carbon atom bonded to two other carbon atoms and one or two hydrogen atoms. This structure gives cyclopentane its characteristic "bowl-shaped" geometry, which allows it to undergo various chemical reactions, such as ring-opening reactions, that can lead to the formation of other chemicals.

Cyclopentanes have a variety of industrial and commercial applications. For example, they are used in the production of plastics, resins, and synthetic rubbers. They also have potential uses in the development of new drugs and medical technologies, as their unique structure and reactivity make them useful building blocks for the synthesis of complex molecules.

Respiratory Syncytial Virus (RSV) infections refer to the clinical illnesses caused by the Respiratory Syncytial Virus. RSV is a highly contagious virus that spreads through respiratory droplets, contact with infected surfaces, or direct contact with infected people. It primarily infects the respiratory tract, causing inflammation and damage to the cells lining the airways.

RSV infections can lead to a range of respiratory illnesses, from mild, cold-like symptoms to more severe conditions such as bronchiolitis (inflammation of the small airways in the lungs) and pneumonia (infection of the lung tissue). The severity of the infection tends to depend on factors like age, overall health status, and presence of underlying medical conditions.

In infants and young children, RSV is a leading cause of bronchiolitis and pneumonia, often resulting in hospitalization. In older adults, people with weakened immune systems, and those with chronic heart or lung conditions, RSV infections can also be severe and potentially life-threatening.

Symptoms of RSV infection may include runny nose, cough, sneezing, fever, wheezing, and difficulty breathing. Treatment typically focuses on managing symptoms and providing supportive care, although hospitalization and more aggressive interventions may be necessary in severe cases or for high-risk individuals. Preventive measures such as hand hygiene, wearing masks, and avoiding close contact with infected individuals can help reduce the spread of RSV.

DNA primers are short single-stranded DNA molecules that serve as a starting point for DNA synthesis. They are typically used in laboratory techniques such as the polymerase chain reaction (PCR) and DNA sequencing. The primer binds to a complementary sequence on the DNA template through base pairing, providing a free 3'-hydroxyl group for the DNA polymerase enzyme to add nucleotides and synthesize a new strand of DNA. This allows for specific and targeted amplification or analysis of a particular region of interest within a larger DNA molecule.

A viral genome is the genetic material (DNA or RNA) that is present in a virus. It contains all the genetic information that a virus needs to replicate itself and infect its host. The size and complexity of viral genomes can vary greatly, ranging from a few thousand bases to hundreds of thousands of bases. Some viruses have linear genomes, while others have circular genomes. The genome of a virus also contains the information necessary for the virus to hijack the host cell's machinery and use it to produce new copies of the virus. Understanding the genetic makeup of viruses is important for developing vaccines and antiviral treatments.

Ubiquitin is a small protein that is present in most tissues in the body. It plays a critical role in regulating many important cellular processes, such as protein degradation and DNA repair. Ubiquitin can attach to other proteins in a process called ubiquitination, which can target the protein for degradation or modify its function.

Ubiquitination involves a series of enzymatic reactions that ultimately result in the attachment of ubiquitin molecules to specific lysine residues on the target protein. The addition of a single ubiquitin molecule is called monoubiquitination, while the addition of multiple ubiquitin molecules is called polyubiquitination.

Polyubiquitination can serve as a signal for proteasomal degradation, where the target protein is broken down into its component amino acids by the 26S proteasome complex. Monoubiquitination and other forms of ubiquitination can also regulate various cellular processes, such as endocytosis, DNA repair, and gene expression.

Dysregulation of ubiquitin-mediated protein degradation has been implicated in a variety of diseases, including cancer, neurodegenerative disorders, and inflammatory conditions.

Monoclonal antibodies are a type of antibody that are identical because they are produced by a single clone of cells. They are laboratory-produced molecules that act like human antibodies in the immune system. They can be designed to attach to specific proteins found on the surface of cancer cells, making them useful for targeting and treating cancer. Monoclonal antibodies can also be used as a therapy for other diseases, such as autoimmune disorders and inflammatory conditions.

Monoclonal antibodies are produced by fusing a single type of immune cell, called a B cell, with a tumor cell to create a hybrid cell, or hybridoma. This hybrid cell is then able to replicate indefinitely, producing a large number of identical copies of the original antibody. These antibodies can be further modified and engineered to enhance their ability to bind to specific targets, increase their stability, and improve their effectiveness as therapeutic agents.

Monoclonal antibodies have several mechanisms of action in cancer therapy. They can directly kill cancer cells by binding to them and triggering an immune response. They can also block the signals that promote cancer growth and survival. Additionally, monoclonal antibodies can be used to deliver drugs or radiation directly to cancer cells, increasing the effectiveness of these treatments while minimizing their side effects on healthy tissues.

Monoclonal antibodies have become an important tool in modern medicine, with several approved for use in cancer therapy and other diseases. They are continuing to be studied and developed as a promising approach to treating a wide range of medical conditions.

Madin-Darby Canine Kidney (MDCK) cells are a type of cell line that is derived from the kidney of a normal, healthy female cocker spaniel. They were first established in 1958 by researchers Madin and Darby. These cells are epithelial in origin and have the ability to form tight junctions, which makes them a popular choice for studying the transport of molecules across biological barriers.

MDCK cells are widely used in scientific research, particularly in the fields of cell biology, virology, and toxicology. They can be used to study various aspects of cell behavior, including cell adhesion, migration, differentiation, and polarization. Additionally, MDCK cells are susceptible to a variety of viruses, making them useful for studying viral replication and host-virus interactions.

In recent years, MDCK cells have also become an important tool in the development and production of vaccines. They can be used to produce large quantities of virus particles that can then be purified and used as vaccine antigens. Overall, Madin-Darby Canine Kidney cells are a valuable resource for researchers studying a wide range of biological phenomena.

BALB/c is an inbred strain of laboratory mouse that is widely used in biomedical research. The strain was developed at the Institute of Cancer Research in London by Henry Baldwin and his colleagues in the 1920s, and it has since become one of the most commonly used inbred strains in the world.

BALB/c mice are characterized by their black coat color, which is determined by a recessive allele at the tyrosinase locus. They are also known for their docile and friendly temperament, making them easy to handle and work with in the laboratory.

One of the key features of BALB/c mice that makes them useful for research is their susceptibility to certain types of tumors and immune responses. For example, they are highly susceptible to developing mammary tumors, which can be induced by chemical carcinogens or viral infection. They also have a strong Th2-biased immune response, which makes them useful models for studying allergic diseases and asthma.

BALB/c mice are also commonly used in studies of genetics, neuroscience, behavior, and infectious diseases. Because they are an inbred strain, they have a uniform genetic background, which makes it easier to control for genetic factors in experiments. Additionally, because they have been bred in the laboratory for many generations, they are highly standardized and reproducible, making them ideal subjects for scientific research.

I'm sorry for any confusion, but "Japan" is not a medical term. Japan is the name of a country, officially known as Nippon-koku or Nihon-koku in Japanese, and is located in East Asia. It is an island nation in the Pacific Ocean with a population of about 126 million people.

If you have any medical questions or terms that you would like me to define, please let me know!

West Nile Virus (WNV) is an Flavivirus, which is a type of virus that is spread by mosquitoes. It was first discovered in the West Nile district of Uganda in 1937 and has since been found in many countries throughout the world. WNV can cause a mild to severe illness known as West Nile fever.

Most people who become infected with WNV do not develop any symptoms, but some may experience fever, headache, body aches, joint pain, vomiting, diarrhea, or a rash. In rare cases, the virus can cause serious neurological illnesses such as encephalitis (inflammation of the brain) or meningitis (inflammation of the membranes surrounding the brain and spinal cord). These severe forms of the disease can be fatal, especially in older adults and people with weakened immune systems.

WNV is primarily transmitted to humans through the bite of infected mosquitoes, but it can also be spread through blood transfusions, organ transplants, or from mother to baby during pregnancy, delivery, or breastfeeding. There is no specific treatment for WNV, and most people recover on their own with rest and supportive care. However, hospitalization may be necessary in severe cases. Prevention measures include avoiding mosquito bites by using insect repellent, wearing long sleeves and pants, and staying indoors during peak mosquito activity hours.

I'm sorry for any confusion, but "poultry" is not a medical term. It is a agricultural and culinary term that refers to domestic birds (such as chickens, ducks, geese, and turkeys) that are kept for their eggs, meat, or feathers. The study and care of these birds would fall under the field of veterinary medicine, but "poultry" itself is not a medical term.

I'm sorry for any confusion, but "Taiwan" is not a medical term or concept. It is the name of an island nation located in East Asia. The official name of the country is the Republic of China (ROC). If you have any medical questions or inquiries, I would be happy to help answer those for you!

Gene expression regulation, viral, refers to the processes that control the production of viral gene products, such as proteins and nucleic acids, during the viral life cycle. This can involve both viral and host cell factors that regulate transcription, RNA processing, translation, and post-translational modifications of viral genes.

Viral gene expression regulation is critical for the virus to replicate and produce progeny virions. Different types of viruses have evolved diverse mechanisms to regulate their gene expression, including the use of promoters, enhancers, transcription factors, RNA silencing, and epigenetic modifications. Understanding these regulatory processes can provide insights into viral pathogenesis and help in the development of antiviral therapies.

Molecular evolution is the process of change in the DNA sequence or protein structure over time, driven by mechanisms such as mutation, genetic drift, gene flow, and natural selection. It refers to the evolutionary study of changes in DNA, RNA, and proteins, and how these changes accumulate and lead to new species and diversity of life. Molecular evolution can be used to understand the history and relationships among different organisms, as well as the functional consequences of genetic changes.

... influenza A virus is the most severe, influenza B virus is less severe but can still cause outbreaks, and influenza C virus is ... ICTVdB database for Influenza viruses Wikispecies has information related to Influenza D virus. Influenza Research Database ... Influenza D virus is 50% similar in amino acid composition to influenza C virus, similar to the level of divergence between ... Influenza viruses A and B also cause seasonal epidemics every year due to their ability to antigenic shift. Influenza viruses C ...
... of influenza virus genome. Pseudoknots are commonly found in viral genomes, especially RNA viruses, where they incorporate an ... The Influenza virus pseudoknot is an RNA pseudoknot structure formed in one of the non-structural coding segments (NS) ... Non-coding RNA Gultyaev AP, Olsthoorn RC (March 2010). "A family of non-classical pseudoknots in influenza A and B viruses". ... Gultyaev AP, Heus HA, Olsthoorn RC (February 2007). "An RNA conformational shift in recent H5N1 influenza A viruses". ...
... (NP) is a structural protein which encapsidates the negative strand viral RNA. NP is one of the ... Burger H, Steuler H, Schroder B, Scholtissek C (1985). "Sequence of the nucleoprotein gene of influenza A/parrot/Ulster/73". ... Virus Res. 3 (1): 35-40. doi:10.1016/0168-1702(85)90039-5. PMID 4024728. This article incorporates text from the public domain ...
... subtype H1N1 Influenza A virus subtype H1N2 Influenza A virus subtype H2N2 Influenza A virus subtype H2N3 ... Influenza A virus subtype H3N1 Influenza A virus subtype H3N2 Influenza A virus subtype H3N8 Influenza A virus subtype H5N1 ... Influenza A virus subtype H5N2 Influenza A virus subtype H5N3 Influenza A virus subtype H5N6 Influenza A virus subtype H5N8 ... Influenza A virus subtype H5N9 Influenza A virus subtype H6N1 Influenza A virus subtype H6N2 Influenza A virus subtype H7N1 ...
Two influenza A viruses and two influenza B viruses are among the four flu viruses that a quadrivalent vaccine is intended to ... Influenza B virus is the only species in the genus Betainfluenzavirus in the virus family Orthomyxoviridae. Influenza B virus ... the influenza A(H1N1), influenza A(H3N2), and one influenza B virus. The second lineage of the B virus was since added to ... influenza B viruses evolve slower than A viruses and faster than C viruses". Influenzavirus B mutates at a rate 2 to 3 times ...
... influenza A virus is the most severe, influenza B virus is less severe but can still cause outbreaks, and influenza C virus is ... in the virus family Orthomyxoviridae, which like other influenza viruses, causes influenza. Influenza C viruses are known to ... ICTVdB database for Influenza viruses Wikispecies has information related to Influenza C virus. Influenza Research Database ... Influenza D virus is 50% similar in amino acid composition to influenza C virus, similar to the level of divergence between ...
North American swine influenza, North American avian influenza, human influenza, and swine influenza virus typically found in ... The G4 virus, also known as the "G4 swine flu virus" (G4) and "G4 EA H1N1", is a swine influenza virus strain discovered in ... In virology, influenza A virus subtype H1N1 (A/H1N1) is a subtype of influenza A virus. Major outbreaks of H1N1 strains in ... Influenza viruses that are normally found in swine are known as swine influenza viruses (SIVs). The known SIV strains include ...
The influenza A virus subtype H10N8 is an avian influenza virus. It is one of three H10 subtype avian influenza viruses ... "Influenza Type A Viruses". cdc.gov. Retrieved 20 April 2020. (Articles with short description, Short description matches ... The first A/H10N8 virus was isolated from a duck in Guangdong province, China, in 2012. The virus shows high pathogenicity in ... Genome sequencing and virus characterization suggest that the virus strains that infected humans originated from poultry ...
"Outbreaks of avian influenza H6N2 viruses in chickens arose by a reassortment of H6N8 and H9N2 ostrich viruses". Virus Genes. ... Avian influenza, Subtypes of Influenza A virus, All stub articles, Virus stubs). ... H6N2 is an avian influenza virus with two forms: one has a low and the other a high pathogenicity. It can cause a serious ... Transmission of avian influenza viruses from wild aquatic birds to domestic birds usually cause subclinical infections, and ...
H7N1 is a subtype of the species Influenza A virus (sometimes called bird flu virus).[citation needed] H7N1 was first isolated ... "WHO - Avian influenza A(H5N1)- update 31: Situation (poultry) in Asia: need for a long-term response, comparison with previous ...
Viruses portal Antigenic shift Influenza A virus subtype H9N2 Influenza A virus subtype H5N1 Pandemic H1N1/09 virus Influenza ... is a bird flu strain of the species Influenza virus A (avian influenza virus or bird flu virus). Avian influenza A H7 viruses ... Avian influenza A H7 viruses are a group of influenza viruses that normally circulate among birds. H7 influenza infections in ... The avian influenza A(H7N9) virus is a subgroup among this larger group of H7 viruses. Although some H7 viruses (e.g. H7N2, ...
... (A/H10N7) is a subtype of the species Influenza A virus (sometimes called bird flu virus). ... Zohari, S; Neimanis, A; Härkönen, T; Moraeus, C; Valarcher, J F (20 November 2014). "Avian influenza A(H10N7) virus involvement ... Influenza Research Database Database of influenza sequences and related information. (Articles with short description, Short ... The Influenza A (H10N7) virus was also held responsible for an increased mortality of harbour seals (Phoca vitulina) in Europe ...
... (A/H3N2) is a subtype of viruses that causes influenza (flu). H3N2 viruses can infect birds and ... and 84 novel influenza A (H1N1) viruses. All 947 influenza seasonal A (H1) viruses are related to the influenza A (H1N1) ... 947 influenza A (H1), 162 influenza A (H3) and 458 influenza B viruses] collected by U.S. laboratories since October 1, 2008, ... reference virus selected by WHO as a potential candidate for novel influenza A (H1N1) vaccine. Influenza B viruses currently ...
... (A/H7N7) is a subtype of Influenza A virus, a genus of Orthomyxovirus, the viruses responsible ... "2. How the Virus Spread from Poultry to People and Pigs". Highly Pathogenic Avian Influenza Virus HPAI H7N7 - 2003 Epidemic in ... February 2004). "Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory ... Influenza Research Database-Database of influenza genomic sequences and related information (CS1 Spanish-language sources (es ...
... (A/H1N2) is a subtype of the species Influenza A virus (sometimes called bird flu virus). It is ... The virus does not cause more severe illness than other influenza viruses, and no unusual increases in influenza activity have ... Between December 1988 and March 1989, 19 influenza H1N2 virus isolates were identified in 6 cities in China, but the virus did ... CDC (2017-04-13). "Information on Avian Influenza". Influenza Research Database Database of influenza genomic sequences and ...
... is the first journal to specialise exclusively on influenza and other respiratory ... Influenza and Other Respiratory Viruses is a peer-reviewed scientific journal covering virology, published by John Wiley & Sons ... Influenza and Other Respiratory Viruses". 2020 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. ... for the International Society for Influenza and other Respiratory Virus Diseases. As of 2018, the editor is Benjamin Cowling. ...
... (A/H7N3) is a subtype of the species Influenza A virus (sometimes called bird flu virus). In ... Comparative Pathobiology of Low and High Pathogenicity H7N3 Chilean Avian Influenza Viruses in Chickens Influenza Research ... The virus is not transmitted from hens to their eggs. "CDC - NIOSH Publications and Products - Protecting Poultry Workers from ... Two humans, both poultry workers, were infected and had symptoms including conjunctivitis and mild influenza-like illness. Both ...
... (A/H6N1), is a subtype of the influenza A virus. It has only infected one person, a woman in ... Subtypes of Influenza A virus, All stub articles, Virus stubs). ... "Characterization of the Influenza a Virus Gene Pool in Avian ... "Origin and Molecular Characteristics of a Novel 2013 Avian Influenza A(H6N1) Virus Causing Human Infection in Taiwan". Clinical ...
... (A/H7N2) is a subtype of the species Influenza A virus. This subtype is one of several sometimes ... H7N2 is considered a low pathogenicity avian influenza (LPAI) virus. With this in mind, H5 & H7 influenza viruses can re-assort ... CDC: Influenza Type A Viruses "flu research". Archived from the original on 2012-07-16. Retrieved 2006-01-27. "NYC DOHMH 2016 ... in Manhattan Research Update on H7n2 Avian Influenza Virus in Turkeys and Chickens Epidemiology of an H7N2 Avian Influenza ...
Swain, David (25 March 2008). Avian Influenza. Wiley. ISBN 9780813820477. Highly Pathogenic Avian Influenza A(H5N8) Virus from ... H5N8 is a subtype of the influenza A virus (sometimes called bird flu) and is highly lethal to wild birds and poultry. H5N8 is ... The virus saw over 7,000 birds succumbing to the virus. As a result, the company, culled over 140,000 birds to prevent the ... In Nigeria, it was reported that the virus affected 3.5 million birds. The virus was also detected in Spain and Slovenia. ...
H5N6 is a subtype of the species Influenza A virus (sometimes called bird flu virus). Infected birds shed the virus in their ... "Human infections with avian influenza A(H5N6) virus - China". World Health Organization. Archived from the original on December ... Avian Influenza Weekly Update Number 811 "CDC Update on A(H5N6) Bird Flu: How is the U.S. CDC Monitoring A(H5N6) Infections and ... The virus was first detected in poultry in 2013, since then spreading among wild bird populations and poultry around the world ...
H3N1 is a subtype of the species Influenza A virus, mostly affecting pigs. The known subtypes of Influenza A virus that create ... strains named by isolate Fujian flu strains named by typical host Bird flu Dog flu Horse flu Human flu Swine flu "Influenza in ... influenza in pigs and are endemic in pigs are H1N1, H1N2, H3N1 and H3N2. ...
... may refer to: Influenza A virus subtype H7N1 Influenza A virus subtype H7N2 Influenza A virus ... subtype H7N3 Influenza A virus subtype H7N4 Influenza A virus subtype H7N7 Influenza A virus subtype H7N9 This disambiguation ... page lists articles associated with the title Influenza A virus subtype H7. If an internal link led you here, you may wish to ...
... is a subtype of viruses that causes influenza (flu). It is mostly present in wild avian species ... "Influenza A virus surveillance in live-bird markets: first report of influenza A virus subtype H4N6, H4N9, and H10N3 in ... Existing studies show that H10 influenza viruses are present in a wide range of domestic and wild avian species, as well as in ... v t e (Articles with short description, Short description is different from Wikidata, Subtypes of Influenza A virus, All stub ...
H5N3 is a subtype of the species Influenza A virus (sometimes called the bird flu virus). H5N3 was identified in Quebec in ... Subtypes of Influenza A virus, All stub articles, Virus stubs). ... H5N3 virus was identified at a farm in La Garnache, France in ... Samples showed that the birds were infected with the H5N3 virus. "H5N2 H5N3 and H5N9 Detected in Quebec and British Columbia ... Gesell, Sina (December 3, 2013). "Avian influenza on ostrich farm: what does a veterinarian say?". Badische Zeitung. Retrieved ...
... which served as a control and largely caused mild pneumonia similar to seasonal influenza A viruses, the swine H2N3 virus was ... H2N3 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteins on the surface of its ... "Recently Emerged Swine Influenza a Virus (H2N3) Causes Severe Pneumonia in Cynomolgus Macaques". PLOS ONE. 7 (7): e39990. ... Both viruses replicated in the entire respiratory tract, but only swine H2N3 could be isolated from lung tissue on day 6 post ...
... N1 Influenza A virus subtype H5N2 Influenza A virus subtype H5N3 Influenza A virus subtype H5N4 ... Influenza A virus subtype H5N5 Influenza A virus subtype H5N6 Influenza A virus subtype H5N7 Influenza A virus subtype H5N8 ... Influenza A virus subtype H5 may refer to one of nine subtypes of Influenza A virus: ... Influenza A virus subtype H5N9 This disambiguation page lists articles associated with the title Influenza A virus subtype H5. ...
H5 N2 is a subtype of the species Influenzavirus A (avian influenza virus or bird flu virus). The subtype infects a wide ... Low pathogenic avian influenza H5N2 virus in poultry later gained accentuated virulence in the United States and Mexico. A ... Notifiable Avian Influenza - Ontario - 2016" [7] Listin Diario Article"Detectan virus gripe aviar en HigĂĽey y Santo Domingo" In ... to Reduce Exposure to Highly Pathogenic Avian Influenza A H5 Viruses". www.cdc.gov. Retrieved 2015-07-31. Regional News Service ...
... (A/H2N2) is a subtype of Influenza A virus. H2N2 has mutated into various strains including the ... This H2N2 virus was composed of three different genes from an H2N2 virus that originated from an avian influenza A virus, ... chose the 1957 strain instead of one of the less deadly avian influenza virus subtypes. The 1957 H2N2 virus is considered ... biological and genetic analysis of avian and human H2N2 viruses Influenza Research Database Database of influenza sequences and ...
... (A/H9N2) is a subtype of the species Influenza A virus (bird flu virus). Since 1998 a total of ... and H5N1 viruses. Moreover, H7N9 influenza viruses continued to reassort with circulating H9N2 viruses, resulting in multiple ... In China, which is regarded as a breeding ground of avian influenza viruses, the H9N2 virus has been detected in multiple avian ... Recent human infections with avian influenza virus revealed that H9N2 is the gene donor for H7N9 and H10N8 viruses that are ...
Algorithm: Interpreting Influenza Testing Results When Influenza is Circulating. *Algorithm: Interpreting Influenza Testing ... Table 1: Influenza Virus Testing Methods. Method1. Types Detected. Acceptable Specimens2. Test Time. CLIA Waived3. ... Information for Clinicians on Influenza Virus Testingplus icon*Clinical Guidance for Hospitalized and Non-Hospitalized Patients ... Serological testing for detection of antibodies to seasonal influenza viruses is useful for research studies and requires ...
Mission Statement: Influenza and Other Respiratory Viruses is the first journal to specialise exclusively on influenza and ... Early Occurrence of Influenza A Epidemics Coincided With Changes in Occurrence of Other Respiratory Virus Infections How does ... Survey of Influenza and Other Respiratory Viruses Diagnostic Testing in US Hospitals, 2012-2013 What are the diagnostic ... Estimating the Hospitalization Burden Associated With Influenza and Respiratory Syncytial Virus in New York City, 2003-2011 ...
Human infection with avian influenza A(H5N6) virus in China http://www.who.int/csr/don/6-may-2016-ah5n6-china/en/ ...
Influenza A (H3N2) Variant Virus & Historical Seasonal H3N2 Influenza Viruses Antibodies (Surplus) (SSIF_F_R) RDC Only Data ... Human infections with influenza A (H3N2) variant virus in the United States, 2011-2012. Clin Infect Dis, 2013. 57 Suppl 1: p.S4 ... Swine-origin influenza A (H3N2) virus infection in two children-Indiana and Pennsylvania, July-August 2011. MMWR Morb Mortal ... SSAIND6 - Influenza A/Indiana/6/ 2013 H3N2. Variable Name: SSAIND6. SAS Label: Influenza A/Indiana/6/ 2013 H3N2. English Text: ...
Global Health Observatory Data Repository (South-East Asia Region) , Global influenza virological surveillance. ...
... influenza A virus is the most severe, influenza B virus is less severe but can still cause outbreaks, and influenza C virus is ... ICTVdB database for Influenza viruses Wikispecies has information related to Influenza D virus. Influenza Research Database ... Influenza D virus is 50% similar in amino acid composition to influenza C virus, similar to the level of divergence between ... Influenza viruses A and B also cause seasonal epidemics every year due to their ability to antigenic shift. Influenza viruses C ...
Influenza virus is one of the most changeable viruses known. There are two ways that influenza virus changes - these are called ... protein of the virus that determines which cell type the virus can enter. As with other viruses, the influenza virus must ... Influenza pandemics are caused by type A viruses, and therefore these are the most feared type of influenza virus; neither ... influenza A virus arise as a result of the acquisition of genes from influenza viruses of other animal species by a human virus ...
How has the influenza vaccine evolved to match the evolution of influenza viruses? ... In 1940, a second strain of influenza virus was isolated; this was named influenza B and the first strain was named influenza A ... Box 1. Current nomenclature for influenza viruses (WHO 1980). The formal nomenclature for the designation of influenza viruses ... 2010fluarix-quadrivalent-fluzone-quadrivalent-influenza-virus-vaccine-quadrivalent-999829. Drugs influenza virus vaccine ...
Influenza Virus Resource. taxonomy/phylogenetic. NCBI taxonomy bookmarks. Notes:. Groups interested in participating in the ... Influenza A virus (A/Bulgaria/155/2008(H1N1)). Taxonomy ID: 569683 (for references in articles please use NCBI:txid569683). ... NCBI BLAST name: viruses. Rank: no rank. Genetic code: Translation table 1 (Standard). Host: human,vertebrates. Lineage( full ) ... View and Analyze sequences in NCBI Virus. ICTV homepage. External Information Resources (NCBI LinkOut). LinkOut. Subject. ...
To investigate the function of apoptotic monocyte disassembly, we used influenza A virus (IAV) infection as a proof-of-concept ... study apoptotic bodies formed when Influenza A (IAV)-infected monocytes undergo apoptosis. They find that apoptotic bodies ... This study suggests that apoptotic bodies may take part in virus propagation and/or clearance. ... Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl Acad. Sci. USA 107, ...
The virus should be studied as a potential source for human influenza, the CDC says. ... A new flu viruses has been identified in fruit bats, but currently, it is not capable of infecting people, according to the CDC ... For this bat influenza virus to infect humans, it would need to obtain genetic properties of human influenza viruses. Gene ... would need to be capable of being infected with both this new bat influenza virus and human influenza viruses," for it to ...
Advice and warnings for the use of Influenza virus vaccine, h5n1 (Audenz) during pregnancy. ... Influenza virus vaccine, h5n1 Pregnancy and Breastfeeding Warnings. Influenza virus vaccine, h5n1 is also known as: Audenz ... Influenza Virus Vaccine, H5N1, Inactivated (influenza virus vaccine, H5N1, inactivated). GlaxoSmithKline. 2022. ... Influenza Virus Vaccine, H5N1, Inactivated (influenza virus vaccine, H5N1, inactivated). GlaxoSmithKline. 2022. ...
... influenza virus vaccine quadrivalent, intranasal), frequency-based adverse effects, comprehensive interactions, ... encoded search term (influenza virus vaccine quadrivalent%2C intranasal (FluMist Quadrivalent)) and influenza virus vaccine ... influenza virus vaccine quadrivalent, intranasal (Rx). Brand and Other Names:FluMist Quadrivalent ... elivaldogene autotemcel, influenza virus vaccine quadrivalent, intranasal. Either decreases effects of the other by Other (see ...
New compound inhibits influenza virus replication New compound inhibits influenza virus replication Researchers from the ... "While other viruses, such as SARS-CoV-2, are able to cap their RNA molecules on their own, influenza viruses rely on stealing ... The influenza virus snatches the cap part of the mature host RNA to start viral replication. MTr1-deficient cells or cells ... To escape this, influenza viruses have developed a special mechanism. They steal the molecular cap from cellular RNA molecules ...
... influenza centres in the Eastern Mediterranean Region for timely and effective detection of seasonal and pandemic influenza. ... on influenza virus identification and handling mechanisms to enhance the capacities of national ... Laboratory technician identifies the type of virus using WHO standard influenza kits during influenza virus identification ... on influenza virus identification and handling mechanisms to enhance the capacities of national influenza centres in the ...
... virus (pH1N1). These viruses are considered reassortant viruses between a swine-origin influenza A (H3N2) virus circulating in ... these tests will not differentiate S-OtrH3N2 from seasonal influenza A viruses. Clinicians who suspect swine influenza virus ... Transmission of swine-origin influenza A (H3N2) viruses not containing the M gene from the pH1N1 virus to humans from close ... State health departments are advised to report suspect novel influenza viruses detected through influenza surveillance promptly ...
... and pandemics can arise from the transmission of novel zoonotic influenza A viruses to humans1,2. Influenza A viruses ... Structures of RNA polymerase of human and avian influenza A viruses reveal that the interface of the RNA polymerase dimer ... and avian influenza A/duck/Fujian/01/2002 (H5N1) viruses at a resolution of 3.0-4.3 Ă…, in the presence or absence of ... Although the high-resolution crystal structure of FluPolA of bat influenza A virus has previously been reported6, there ...
Natalie J. Thornburg, David P. Nannemann, David L. Blum, Jessica A. Belser, Terrence M. Tumpey, Shyam Deshpande, Gloria A. Fritz, Gopal Sapparapu, Jens C. Krause, Jeong Hyun Lee, Andrew B. Ward, David E. Lee, Sheng Li, Katie L. Winarski, Benjamin W. Spiller, Jens Meiler, James E. Crowe Jr.. ...
Animals, Biofilms, Cell Line, Tumor, Epithelial Cells, Humans, Influenza A virus, Mice, Mice, Inbred BALB C, Orthomyxoviridae ... However, influenza A virus (IAV) infection releases virulent pneumococci from biofilms in vitro and in vivo. Triggers of ... However, influenza A virus (IAV) infection releases virulent pneumococci from biofilms in vitro and in vivo. Triggers of ... However, influenza A virus (IAV) infection releases virulent pneumococci from biofilms in vitro and in vivo. Triggers of ...
... Nat Immunol. 2011 Nov;12(11):1045-54 ... Notably, mouse ILCs accumulated in the lung after infection with influenza virus, and depletion of ILCs resulted in loss of ... role for lung ILCs in restoring airway epithelial integrity and tissue homeostasis after infection with influenza virus. ...
The causative agent behind this outbreak was identified as H5N1 highly pathogenic avian influenza virus (HPAIV). Genetic and ... a highly unusual symptom with influenza infections in humans. Furthermore, this virus was shown to be highly pathogenic to both ... Due to the geographical location of Sanmenxia, these novel H5N1 viruses also have the potential to be imported to other regions ... Sanmenxia Clade 2.3.2.1c-like H5N1 viruses possess the closest genetic identity to A/Alberta/01/2014 (H5N1), which recently ...
Scientists showed that the vaccine is more effective at reducing transmission of influenza. ... the 2009 H1N1 influenza virus that caused a pandemic, emerged suddenly. The pandemic influenza strain was identified in April ... Universal influenza vaccine candidate reduces transmission of virus best when given nasally in mice. * Share ... Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of ...
Influenza virus and respiratory syncytial virus (RSV) disease have been increasing in Orange County for the last several weeks ... We will be posting current data on influenza epidemiology on a weekly basis on the OCHCA Influenza page. ... quadrivalent recombinant influenza vaccine (RIV4), or quadrivalent adjuvanted inactivated influenza vaccine (aIIV4) whenever ... Influenza Vaccine Recommendations provides current recommendations for influenza vaccination. These include the new ...
Face masks to prevent transmission of influenza virus: a systematic review - Volume 138 Issue 4 ... While influenza virus could be detected by RT-PCR in all nine volunteers without a mask, no influenza virus could be detected ... Attitudes of influenza-vaccinated health care workers toward masks to prevent nosocomial transmission of influenza. Influenza ... A review of medical masks and respirators for use during an influenza pandemic. Influenza and Other Respiratory Viruses 2009; 3 ...
ICC/IF and tested in Influenza A. Cited in 33 publication(s). Immunogen corresponding to tissue… ... Mouse monoclonal Influenza A Virus Nucleoprotein antibody [C43]. Validated in WB, ELISA, Flow Cyt, ... Tissue, cells or virus corresponding to Influenza A Virus Nucleoprotein. Human Influenza A Virus H3N2 strain. Database link: ... Microbiology Organism Virus RNA Virus single stranded RNA negative strand virus Influenza Share by email ...
First, IBV viruses were completely inhibited by a novel SUMOylation specific inhibitor, STE025, discovered from our FRET-based ... We therefore propose that the host SUMOylation pathway is a critical host factor for the IBV virus life cycle. The ... Reconstitution of Wild-Type Influenza B Virus (B/Yamagata/16/1988) and M1 Mutant Influenza B Virus (B/Yamagata/16/1988). The ... Time-Dependent Proinflammatory Responses Shape Virus Interference during Coinfections of Influenza A Virus and Influenza D ...
  • This household study identifies risk factors of infection by the pandemic influenza A/H1N1. (medscape.com)
  • The novel virus, commonly called swine flu, is named influenza A (H1N1). (bcm.edu)
  • Fortunately, however, H1N1 is far less deadly than the H5N1 virus. (bcm.edu)
  • In only a few short weeks after emerging in North America, the new H1N1 virus reached around the world. (bcm.edu)
  • Although the 2009 H1N1 pandemic did not turn out to be as deadly as initially feared, the next pandemic flu virus could emerge at any time, and we must remain vigilant. (bcm.edu)
  • Hopefully, the knowledge gained in response to the H5N1 and 2009 H1N1 outbreaks, and continued research to more completely understand influenza virus, as well as improvements in vaccine and drug development, will enable us to minimize the effects of future influenza outbreaks. (bcm.edu)
  • The A/PR8 (H1N1) strain used, which was isolated in Puerto Rico in 1934, had a high replication potential in eggs, which enabled the required huge quantities of virus to be obtained. (medscape.com)
  • Previous pandemics of the 20th century, as well as the 2009 H1N1 pandemic , were caused by influenza viruses in animals that gained the ability to infect and spread easily between humans. (livescience.com)
  • The most recent 10 cases, including the three Iowa cases described in this report, were infections with S-OtrH3N2 viruses containing the matrix (M) gene from the pandemic 2009 influenza A (H1N1) virus (pH1N1). (cdc.gov)
  • As an example of the type of public health gap to be filled, the 2009 H1N1 influenza virus that caused a pandemic, emerged suddenly. (fda.gov)
  • Reacts with NP of all influenza A viruses so far tested, including seasonal H2N2, H3N2(A/Sydney/5/1997), and H5N1(A/crow/Kyoto53/2004), H5N1 (A/duck/Egypt/D2br10/07), H5N1(A/duck/HK/342/78), H5N2(A/crow/Kyoto/53/04), H9N1, H9N2 (A/Turkey/Wisconsin/1/66) and H1N1 (seasonal: A/New Caledonia/20/99. (abcam.com)
  • Many national and international health agencies recommended the use of face masks during the 2009 influenza A (H1N1) pandemic. (cambridge.org)
  • Pandemic influenza A (H1N1) virus emerged in Mexico in early 2009 and rapidly spread worldwide. (cambridge.org)
  • While much knowledge regarding the virus has been discovered, we are still no closer to having the ability to predict the next pandemic, such as in the case of 2009 H1N1 pandemic. (springer.com)
  • Is there a difference between being diagnosed with Influenza A and H1N1? (virology.ws)
  • The 1918 virus spread through the pig population, adapted to the swine and resulted in the current lineage of the H1N1 swine influenza viruses. (scienceblog.com)
  • For the study, the researchers used the 1918 pandemic virus and a 1930 H1N1 influenza virus for experimental infections in swine. (scienceblog.com)
  • Over the last four epidemiological weeks (EWs), the predominant influenza viruses have been influenza A(H1N1)pdm09, with concurrent circulation of influenza B/Victoria, and to a lesser extent, influenza A(H3N2). (paho.org)
  • During this period, the predominant viruses have been influenza B/Victoria, with lesser circulation of influenza A(H1N1)pdm09 and influenza A(H3N2). (paho.org)
  • Over the last four EWs, the predominant influenza viruses have been influenza B/Victoria, followed by influenza A, mainly A(H1N1)pdm09. (paho.org)
  • Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. (who.int)
  • How safe and effective is the AS03-adjuvanted H5N1 influenza vaccine in children? (medscape.com)
  • Here, using crystallography and cryo-electron microscopy, we determine the structures of FluPol A from human influenza A/NT/60/1968 (H3N2) and avian influenza A/duck/Fujian/01/2002 (H5N1) viruses at a resolution of 3.0-4.3 Ă…, in the presence or absence of a cRNA or vRNA template. (nature.com)
  • The causative agent behind this outbreak was identified as H5N1 highly pathogenic avian influenza virus (HPAIV). (nature.com)
  • Genetic and phylogenetic analyses revealed that this Sanmenxia H5N1 virus was a novel reassortant, possessing a Clade 2.3.2.1c HA gene and a H9N2-derived PB2 gene. (nature.com)
  • Sanmenxia Clade 2.3.2.1c-like H5N1 viruses possess the closest genetic identity to A/Alberta/01/2014 (H5N1), which recently caused a fatal respiratory infection in Canada with signs of meningoencephalitis, a highly unusual symptom with influenza infections in humans. (nature.com)
  • Due to the geographical location of Sanmenxia, these novel H5N1 viruses also have the potential to be imported to other regions through the migration of wild birds, similar to the H5N1 outbreak amongst migratory birds in Qinghai Lake during 2005. (nature.com)
  • As of 31 March 2015, H5N1 virus caused at least 826 laboratory-confirmed human infections, including 440 deaths across 16 countries 2 . (nature.com)
  • The Qinghai-like Clade 2.2 virus was found to possess a high genetic relationship with viruses isolated from other countries on the migratory flyway of wild birds 4 , suggesting that the migration of wild birds played an important role in circulating H5N1 HPAIV viruses between the different avian populations. (nature.com)
  • This is highlighted by confirmed cases of human infections by highly pathogenic H5N1 viruses, and more recently, the H7N9 outbreak in China [ 5 ]. (springer.com)
  • Similar to H5N1 strains, this further affirms the potential of avian influenza strains capable of directly infecting human, causing severe illnesses. (springer.com)
  • In light of the recent outbreak of avian influenza (H5N1) among ducklings in Guangdong province, there are again concerns over the risk of transmission of avian influenza from poultry and their products to humans. (gov.hk)
  • In a recent study published in the CDC's Emerging Infectious Diseases journal, researchers characterized the pathophysiology of infection by the highly pathogenic avian influenza (HPAI) A (H5N1) viral organism belonging to the Eurasian lineage and 2.3.4.4b clade in non-domesticated terrestrial animals across the United States (US) between 1 April and 21 July 2022. (news-medical.net)
  • In the present study, researchers presented a series of cases to highlight the pathophysiology of spontaneous HPAI H5N1 infections among terrestrial wild animals in the US, which coincided with elevated levels of highly pathogenic avian influenza viruses in circulation among non-domesticated avian species during summer and spring of 2022. (news-medical.net)
  • The team built phylogenetic interpretation trees and single-nucleotide polymorphism (SNP) tables using a reference including six segments from the H5N1 clade 2.3.4.4b virus and two from non-domesticated avian viruses from the northern regions of America. (news-medical.net)
  • Since 2003, multiple highly pathogenic avian influenza A (HPAI) H5 subtypes, including H5N1, H5N2, H5N6, and H5N8, have generated severe epidemics and thus not only tremendous economic losses in the domestic poultry industry, but also serious threats to human health worldwide ( Jhung and Nelson, 2015 ). (frontiersin.org)
  • As of October 3, 2016, at least 856 cases of human infection with avian influenza A (H5N1) virus in 16 countries had been reported to the World Health Organization, among which 452 had ended in death, for an apparent case fatality rate of 52.8% ( WHO, 2016 ). (frontiersin.org)
  • Since its first detection in 1997, highly pathogenic avian influenza (HPAI) H5N1 virus has devastated the poultry industry of numerous countries of the Eastern Hemisphere. (flutrackers.com)
  • As of January 2012, HPAI H5N1 virus caused 577 laboratory-confirmed human cases of infection, of which 340 were fatal. (flutrackers.com)
  • In late December, a sick cat in the Deux-Sèvres dĂ©partement tested positive for the highly pathogenic avian influenza virus H5N1. (anses.fr)
  • ANSES, the national reference laboratory, confirmed the contamination of a cat by the highly pathogenic avian influenza virus H5N1 in late 2022. (anses.fr)
  • In this study, baculovirus pseudotyped with vesicular stomatitis virus glycoprotein was used as a vector to express the hemagglutinin (HA) protein of highly pathogenic H5N1 avian influenza virus, A/Chicken/Hubei/327/2004 (HB/327). (unboundmedicine.com)
  • These data indicate that the pseudotype baculovirus-mediated vaccine could be utilized as an alternative strategy against the pandemic spread of H5N1 influenza virus. (unboundmedicine.com)
  • From H5N1 to HxNy: An epidemiologic overview of human infections with avian influenza in the Western Pacific Region, November 2003 - September 2017. (who.int)
  • 2 November 2017 - WHO conducted a 5-day workshop in Rabat, Morocco, on influenza virus identification and handling mechanisms to enhance the capacities of national influenza centres in the Eastern Mediterranean Region for timely and effective detection of seasonal and pandemic influenza. (who.int)
  • By establishing virus identification and handling mechanisms, and through timely detection of unknown viruses, national influenza centres can be effective in limiting the spread of seasonal and pandemic influenza in the Region, and around the world," said Dr Mamunur Malik, Manager of the Infectious Hazard Management unit at WHO's Health Emergencies Programme at the Regional office in Cairo. (who.int)
  • The pandemic influenza strain was identified in April 2009 and by September 2009, the vaccine was developed and produced, and FDA had approved influenza vaccines from various manufacturers for use by the public. (fda.gov)
  • Pneumococcal infection of the respiratory tract is often secondary to recent influenza virus infection and accounts for much of the morbidity and mortality during seasonal and pandemic influenza. (nih.gov)
  • Their research supports the hypothesis that the 1918 pandemic influenza virus and the virus causing the swine flu were the same. (scienceblog.com)
  • It also suggests that pigs could have played a role in maintaining and spreading the 1918 human pandemic influenza virus. (scienceblog.com)
  • Pandemic Influenza Preparedness (PIP) Framework. (who.int)
  • Gross photographs of postmortem lesions from red foxes naturally infected with highly pathogenic avian influenza virus, United States. (news-medical.net)
  • How effective are seasonal influenza vaccines in tropical communities? (medscape.com)
  • Evolution of influenza viruses and corresponding evolution of influenza vaccines. (medscape.com)
  • Fortunately, initial laboratory testing suggests the new virus would need to undergo significant changes to become capable of infecting and spreading easily among humans," said Dr. Ruben Donis, chief of the Molecular Virology and Vaccines Branch in CDC's Influenza Division. (livescience.com)
  • It focused on detection and identification of seasonal influenza virus sub-types, using cell culture and hemaglutination - steps that are essential for identifying viruses to make vaccines. (who.int)
  • The FDA findings are important because they suggest the vaccine could both protect recipients and reduce transmission -- even when virus strains emerge with differing envelope proteins, a type of change, that when it occurs, can make existing influenza vaccines less effective. (fda.gov)
  • Current vaccines are designed to trigger production of neutralizing antibodies (antibodies that prevent virus from getting into cells) against proteins on the surface of the virus, mainly a protein called HA. (fda.gov)
  • A limitation of such vaccines is that HA mutates frequently, allowing the virus to escape from immunity to an HA-based vaccine. (fda.gov)
  • Unlike seasonal influenza vaccines that induce neutralizing antibodies to HA, immunity to NP and M2 might permit some mild, brief infection. (fda.gov)
  • According to two reports, a number of simple, inexpensive interventions are effective in slowing the spread of respiratory viruses, although current public health guidelines neglect these measures, favoring vaccines and antiviral drugs. (nursingcenter.com)
  • Influenza virus vaccines and reagents. (who.int)
  • The first research programs attempting to develop an inactivated influenza vaccine, outside of the USSR, were conducted in England and in the USA at about the same time. (medscape.com)
  • The relatively simple methods developed by Burnet in Australia for culturing the virus on chick embryos, involving inoculation into the allantoic cavity, made it easy to obtain sufficient amounts of the virus strains for the vaccine. (medscape.com)
  • Thomas Francis, head of the US Army Commission, and his colleagues decided to use a vaccine prepared from allantoic fluid containing high concentrations of virus that had been purified and inactivated with formalin. (medscape.com)
  • [ 8 ] With an inactivated virus vaccine, the amount of antigen required to induce immunity is much greater than that for a live-attenuated virus vaccine, because unlike the live-attenuated virus, the inactivated virus does not replicate in the recipient. (medscape.com)
  • Thus, being able to obtain large quantities of virus in the allantoic fluid overcame this problem and an inactivated vaccine with a sufficiently high concentration of antigen could be prepared, after a simple, rapid purification process. (medscape.com)
  • This virus was named Influenza B and the inactivated influenza vaccine had to be bivalent to provide protection against both types of influenza viruses (Figure 1). (medscape.com)
  • Thus, in 1942, 10,000 doses of the first bivalent vaccine containing the A/PR8 and B/Lee virus strains were administered in humans for testing. (medscape.com)
  • This bivalent vaccine contained 0.5 ml of virus concentrated from 5 ml of allantoic fluid containing influenza A and the same amount of influenza B. One half of the influenza A allantoic fluid contained the A/PR8 strain and the other half contained the Weiss strain, a strain that had been isolated more recently and that was slightly different from A/PR8. (medscape.com)
  • In 1944, Stanley described in detail the preparation and properties of influenza virus vaccine produced in embryonated hen eggs, concentrated and purified by differential centrifugation and inactivated by different procedures. (medscape.com)
  • certolizumab pegol decreases effects of influenza virus vaccine quadrivalent, intranasal by pharmacodynamic antagonism. (medscape.com)
  • Scientists at the U.S. Food and Drug Administration (FDA) have been studying an influenza vaccine candidate that is based on conserved antigens instead, and in animal models protects broadly against widely divergent influenza virus strains. (fda.gov)
  • The scientists have now demonstrated the ability of this universal influenza vaccine candidate to reduce the transmission of influenza virus in mice, even though this vaccine does not completely block infection by the virus. (fda.gov)
  • The candidate vaccine targets two influenza A proteins, A/NP and M2, that do not change from year to year. (fda.gov)
  • That has led some experts to suggest that this type of vaccine would allow continued spread of influenza viruses to other individuals. (fda.gov)
  • However, the new findings show that even without triggering production of neutralizing antibodies, this universal vaccine reduces virus transmission in mice. (fda.gov)
  • In the current study, scientists showed that the vaccine is more effective at reducing transmission of influenza A viruses among mice when it is given intranasally rather than injected intramuscularly. (fda.gov)
  • That model suggested that a vaccine reducing transmission, even if it did not completely prevent infection, could reduce the size of outbreaks and slow the rate of mutation of the virus. (fda.gov)
  • While this timeline is considered rather quick with respect to influenza vaccine development and production, it was not available for use as quickly as it was needed. (fda.gov)
  • Such a vaccine might reduce the number of illnesses and deaths until a vaccine matched to the new virus is developed and distributed. (fda.gov)
  • 65 years to receive either quadrivalent high-dose inactivated influenza vaccine (HD-IIV4), quadrivalent recombinant influenza vaccine (RIV4), or quadrivalent adjuvanted inactivated influenza vaccine (aIIV4) whenever available. (constantcontact.com)
  • Consequently the seasonal trivalent influenza vaccine contains an influenza B virus component. (virology.ws)
  • There is no vaccine against influenza C virus. (virology.ws)
  • This project will explore determine how sequence variation in the UTR's of the influenza vRNA's (particularly, HA and NA) impact the replication/fitness of influenza A viruses by focusing our analysis on the UTR's of high yield reassortants used as vaccine seed stocks and selected naturally circulating strains. (jcvi.org)
  • The sequence of the complete genomes including the HA and NA UTRs of low and high yield reassortant vaccine candidate, and seed stocks and their parental viruses (wild type). (jcvi.org)
  • We will also investigate changes in the HA and NA UTRs of a subset of ~6-10 reassortants vaccine seeds which have been serially passaged in mammalian cell culture or eggs to determine if the substrate/species used to propagate the viruses selects for changes in the UTRs that enhance growth under specific conditions. (jcvi.org)
  • however, hemagglutination-inhibiting antibodies against influenza D virus have been detected in humans, with an estimated occurrence of 1.3% in the general population, suggesting that this virus may infect humans as well. (wikipedia.org)
  • More studies are needed to conclude whether or not the Type D virus can infect humans. (wikipedia.org)
  • Influenza A virus can infect a variety of animals as well as humans, and its natural host or reservoir is birds, whereas influenza viruses B, C, and D do not have animal reservoirs. (wikipedia.org)
  • This study suggests that influenza D virus may be only a few genetic changes away from being able to invade the lower lung, even though the virus does not actively spread among humans and has a much slower mutation rate than the other influenza viruses. (wikipedia.org)
  • There are three different types of influenza virus - A, B, and C. Type A viruses infect humans and several types of animals, including birds, pigs, and horses. (bcm.edu)
  • Type B influenza is normally found only in humans, and type C is mostly found in humans, but has also been found in pigs and dogs. (bcm.edu)
  • For this bat influenza virus to infect humans, it would need to obtain genetic properties of human influenza viruses. (livescience.com)
  • it's a complicated process, but it can sometimes lead to the emergence of new influenza viruses in humans. (livescience.com)
  • Influenza viruses cause respiratory illnesses in humans, and in some animal and bird species. (who.int)
  • A pandemic occurs when an influenza virus which was not previously circulating among humans, and to which most people do not have immunity, emerges and transmits among humans. (who.int)
  • This virus was highly pathogenic in chickens and humans and posed a significant threat to public health. (nature.com)
  • Majority of influenza A viruses reside and circulate among animal populations, seldom infecting humans due to host range restriction. (springer.com)
  • Further understanding and determining host tropism would be important in identifying zoonotic influenza virus strains capable of crossing species barrier and infecting humans. (springer.com)
  • We therefore propose that the synergistic stimulation of type I IFN production during concurrent influenza virus and pneumococcal infection leads to increased bacterial colonization and suggest that this may contribute to the higher rates of disease associated with coinfection in humans. (nih.gov)
  • Ongoing avian influenza outbreaks in animals pose risk to humans: read the situation analysis and advice to countries from the Food and Agriculture Organization of the United Nations (FAO), the World Health Organization (WHO), and the World Organisation for Animal Health (WOAH). (eurosurveillance.org)
  • Since April 2014, new infections of H5N6 avian influenza virus (AIV) in humans and domestic poultry have caused considerable economic losses in the poultry industry and posed an enormous threat to human health worldwide. (frontiersin.org)
  • This property may be a consequence of the limited host range of the virus - humans and seals - which limits the generation of new strains by reassortment. (virology.ws)
  • Swine flu is a respiratory disease of pigs caused by type A influenza that regularly causes outbreaks of influenza among the animals and can be transmitted to humans. (scienceblog.com)
  • Highly pathogenic influenza A virus H5 subtype remains a risk for transmission in humans. (mdpi.com)
  • So far, little is known about how this virus evolves and adapts to infect humans. (mdpi.com)
  • Receptor binding by an H7N9 influenza virus from humans. (flutrackers.com)
  • We conclude that the human H7 virus has acquired some of the receptor-binding characteristics that are typical of pandemic viruses, but its retained preference for avian receptor may restrict its further evolution towards a virus that could transmit efficiently between humans, perhaps by binding to avian-receptor-rich mucins in the human respiratory tract rather than to cellular receptors. (flutrackers.com)
  • Contamination of pets such as cats could make it easier for the virus to cross into humans. (anses.fr)
  • This is because simultaneous infection with an avian influenza virus and a human influenza virus could lead to the emergence of a new influenza virus that is potentially highly contagious to humans. (anses.fr)
  • Influenza serological testing of stored sera from NHA NES 2010 collection across various age groups, were used in this study to determine the population level of cross-reactive antibodies to H3N2v virus and historical seasonal H3N2 viruses. (cdc.gov)
  • This data release contain the hemagglutination inhibition (HI) titers to H3N2v and historical seasonal H3N2 viruses. (cdc.gov)
  • Antibody titers against H3N2v and historical seasonal H3N2 influenza viruses were measured with hemagglutination inhibition (HI) assay at Influenza Division, Centers for Disease Control and Prevention. (cdc.gov)
  • The selected historical H3N2 viruses were: A/Aichi/2/1968, A/Victoria/3/1975, A/Bangkok/1/1979, A/Shanghai/11/1987, A/Beijing/32/1992, A/Wuhan/359/1995, A/Sydney/5/1997, A/Fujian/411/2002, and A/Brisbane/10/2007. (cdc.gov)
  • HI A/AICHI/2/1968: Geometric mean hemagglutination inhibition (HI) titer against the influenza A/H3N2 virus A/Aichi/2/1968. (cdc.gov)
  • HI A/VICTORIA/3/1975: Geometric mean hemagglutination inhibition (HI) titer against the influenza A/H3N2 virus A/Victoria/3/1975. (cdc.gov)
  • HI A/BANGKOK/1/1979: Geometric mean hemagglutination inhibition (HI) titer against the influenza A/H3N2 virus A/Bangkok/1/1979. (cdc.gov)
  • HI A/BRISBANE/10/2007: Geometric mean hemagglutination inhibition (HI) titer against the influenza A/H3N2 virus A/Brisbane/10/2007. (cdc.gov)
  • First H3N2 Variant Virus Infection Reported for 2012. (cdc.gov)
  • On November 20, 2011, CDC confirmed three cases of swine-origin triple reassortant influenza A (H3N2) (S-OtrH3N2) virus infection in children in two counties in Iowa. (cdc.gov)
  • Eighteen human infections with swine-origin influenza A (H3N2) viruses have been identified since 2009 ( 1 , 2 ). (cdc.gov)
  • These viruses are considered reassortant viruses between a swine-origin influenza A (H3N2) virus circulating in North American swine and a pH1N1 virus. (cdc.gov)
  • Even though isolated 3 months later, the March 2019 isolated H3N2 viruses replicated more efficiently than the November 2018 isolated viruses. (flu.org.cn)
  • Specimens were pared with segments in the Global Initiative on Sharing suspended in viral transportation medium (Creative, Tai- All Influenza Data (Table 1). (cdc.gov)
  • The influenza virus snatches the cap part of the mature host RNA to start viral replication. (uni-bonn.de)
  • In response, we examined the viral distribution and mRNA expression profiles of immune-related genes in chickens infected with both viruses. (frontiersin.org)
  • The enveloped influenza A virions have three membrane proteins (HA, NA, M2), a matrix protein (M1) just below the lipid bilayer, a ribonucleoprotein core (consisting of 8 viral RNA segments and three proteins: PA, PB1, PB2), and the NEP/NS2 protein. (virology.ws)
  • Like the influenza A and B viruses, the core of influenza C viruses consists of a ribonucleoprotein made up of viral RNA and four proteins. (virology.ws)
  • The cat, which lived near a duck farm affected by the virus, suffered severe neurological symptoms due to the viral infection and had to be euthanised. (anses.fr)
  • The influenza viruses are the most common viral cause of pneumonia. (medscape.com)
  • Respiratory syncytial virus (RSV) is the most frequent cause of lower respiratory tract infection in infants and children and the second most common viral cause of pneumonia in adults. (medscape.com)
  • Their efficacy in patients with influenza viral pneumonia or severe influenza is unknown. (medscape.com)
  • We found that IFITM3-deficient mice and human cells could be infected with low doses of avian influenza viruses that failed to infect WT counterparts, identifying a new role for IFITM3 in controlling the minimum infectious viral dose threshold. (bvsalud.org)
  • In the spring of 2009, a different influenza virus - one that had never been seen before - suddenly appeared. (bcm.edu)
  • In 1940, for the first time, a different influenza virus was discovered and isolated. (medscape.com)
  • How does the early occurrence of influenza epidemics impact outbreaks of other common seasonal viruses? (medscape.com)
  • Of the four antigenic types, influenza A virus is the most severe, influenza B virus is less severe but can still cause outbreaks, and influenza C virus is usually only associated with minor symptoms. (wikipedia.org)
  • It presents information on the spread of avian influenza (bird flu) viruses among birds and the outbreaks in poultry. (bvs.br)
  • The influenza A subtypes are further classified into strains, and the names of the virus strains include the place where the strain was first found and the year of discovery. (bcm.edu)
  • In addition, features from all 11 proteins were used to construct a combined model to predict host tropism of influenza virus strains. (springer.com)
  • Current understanding of influenza zoonotic transmission potential of novel strains still remains poorly understood. (springer.com)
  • Species barrier limits influenza strains from freely infecting different host organisms as they must overcome host range restriction to adapt to a new host. (springer.com)
  • Avian influenza is an infectious disease of birds caused by type A strains of influenza virus. (gov.hk)
  • The virus, comparable to those found in Eurasian strains, was identified in the US in December of 2021 and spread to domesticated animals and non-domestic birds. (news-medical.net)
  • Reassortment between influenza A(H7N9) and local H9N2 strains has spread from China's south-east coast to other regions. (eurosurveillance.org)
  • Three new reassortments of A(H7N9) virus were identified by phylogenetic analysis: between A(H7N9) and Zhejiang-derived strains, Guangdong/Hong Kong-derived strains or Hunan-derived A(H9N2) strains. (eurosurveillance.org)
  • I showed that the influenza C virus genome consists of 7 RNA segments, and demonstrated reassortment among different influenza C virus strains. (virology.ws)
  • Influenza virus and respiratory syncytial virus (RSV) disease have been increasing in Orange County for the last several weeks. (constantcontact.com)
  • Assure that high risk infants are given Palivizumab, in accordance with AAP recommendations and the recent California Department of Public Health CAHAN advisory Early Respiratory Syncytial Virus Activity and Use of Palivizumab . (constantcontact.com)
  • Respiratory Syncytial Virus (RSV) activity has also remained low, showing a slight increase. (paho.org)
  • before then, Influenza D virus was thought to be a subtype of Influenzavirus C. Cases of infections from the Type D virus are rare compared to Types A, B, and C. Similar to Type C, Type D has 7 RNA segments and encodes 9 proteins, while Types A and B have 8 RNA segments and encode at least 10 proteins. (wikipedia.org)
  • So, for example, a virus with version 1 of the HA protein and version 2 of the NA protein would be called influenza A subtype H1N2 (A H1N2, for short). (bcm.edu)
  • The team performed two tests for influenza A virus H5 subtyping: IAV and H5 subtype hemagglutinin gene targeted-RT-PCR and the H5 subtype clade 2.3.4.4b-targeted RT-PCR for the North American, Eurasian, and Mexican lineages of the virus. (news-medical.net)
  • Influenza A Virus, H10N7 Subtype" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (umassmed.edu)
  • A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 10 and neuraminidase 7. (umassmed.edu)
  • This graph shows the total number of publications written about "Influenza A Virus, H10N7 Subtype" by people in this website by year, and whether "Influenza A Virus, H10N7 Subtype" was a major or minor topic of these publications. (umassmed.edu)
  • Below are the most recent publications written about "Influenza A Virus, H10N7 Subtype" by people in Profiles. (umassmed.edu)
  • Understanding and predicting host tropism of influenza proteins lay an important foundation for future work in constructing computation models capable of directly predicting interspecies transmission of influenza viruses. (springer.com)
  • A total 474 serum specimens were collected in Taiwan dur- positive dogs had antibodies against influenza A(H6N1) vi- ing October 2012-October 2013. (cdc.gov)
  • No serum at the National Taiwan University Veterinary Hospital in samples had antibodies against influenza A(H5N2) virus. (cdc.gov)
  • These viruses also contain proteins on the surface of the cell membrane called glycoproteins. (wikipedia.org)
  • Type A influenza is classified into subtypes depending on which versions of two different proteins are present on the surface of the virus. (bcm.edu)
  • Several influenza proteins have been shown to be major determinants in host tropism. (springer.com)
  • In this study, computational models for 11 influenza proteins have been constructed using the machine learning algorithm random forest for prediction of host tropism. (springer.com)
  • 0.916) capable of determining host tropism of individual influenza proteins. (springer.com)
  • Influenza B virions have four proteins in the envelope: HA, NA, NB, and BM2. (virology.ws)
  • no human infections from this virus have been observed. (wikipedia.org)
  • Influenzavirus D is less common than the other antigenic types, and it is not known to cause any human infections. (wikipedia.org)
  • The researchers want to harness this dependence for the treatment of influenza infections. (uni-bonn.de)
  • In the present study, the researchers were already able to demonstrate that TFMT works together with approved drugs against influenza infections. (uni-bonn.de)
  • In 2006, a Qinghai-like Clade 2.2 virus re-emerged in Qinghai Lake and caused more infections in wild birds, including bar-headed geese and great black-headed gulls. (nature.com)
  • Further studies in controlled settings and studies of natural infections in healthcare and community settings are required to better define the effectiveness of face masks and respirators in preventing influenza virus transmission. (cambridge.org)
  • That's correct - influenza C causes mild upper respiratory tract infections with cold-like symptoms. (virology.ws)
  • Our data demonstrate that IFITM3 deficiency uniquely facilitates zoonotic influenza virus infections and subsequent adaptation, implicating IFITM3 deficiencies in the human population as a vulnerability for emergence of new pandemic viruses . (bvsalud.org)
  • The major influenza C virus envelope glycoprotein is called HEF (hemagglutinin-esterase-fusion) because it has the functions of both the HA and the NA. (virology.ws)
  • The susceptibility of cats to highly pathogenic avian influenza (HPAI) viruses has been known since 2004, and had already been demonstrated in Thailand and Germany in 2006. (anses.fr)
  • Influenza viruses A, B, C, and D represent the four antigenic types of influenza viruses. (wikipedia.org)
  • Serological testing for detection of antibodies to seasonal influenza viruses is useful for research studies and requires collection of appropriately timed acute and convalescent serum specimens and testing of paired sera at specialized research or public health laboratories. (cdc.gov)
  • Molecular detection of influenza A virus nucleotides ( 4 ). (cdc.gov)
  • WHO's Regional Office of the Eastern Mediterranean had conducted an assessment of these centres and influenza laboratories in 2015-2016, which revealed that some lack the necessary capacity for virus isolation in cell culture, and for antigenic characterization of human influenza viruses - capacities that are fundamental for early detection and recognition of influenza viruses of epidemic and pandemic potential. (who.int)
  • This illustration shows the setup of the optofluidic chip for rapid detection of single antigens of SARS-CoV-2 and Influenza A. (Image credit: Stambaugh et al. (ucsc.edu)
  • Researchers at UC Santa Cruz have developed a novel chip-based antigen test that can provide ultrasensitive detection of SARS-CoV-2 and influenza A, the viruses that cause COVID-19 and flu, respectively. (ucsc.edu)
  • WHO External Quality Assessment Project for the detection of influenza virus type A by PCR. (who.int)
  • Squires RC, Reading PC, Sullivan SG, Barr IG, Konings F. Influenza virus detection: driving change in public health laboratories in the Western Pacific Region. (who.int)
  • National influenza centres work closely with sub-national laboratories and WHO collaborating centres to regularly collect and analyse virus specimens in order to identify the type of influenza virus circulating in and out of season. (who.int)
  • 2016) Low-pathogenic avian influenza viruses in wild migratory waterfowl in a region of high poultry production, Delmarva, Maryland. (usgs.gov)
  • The first external quality assessment of isolation and identification of influenza viruses in cell culture in the Asia Pacific region, 2016. (who.int)
  • Some approved rapid influenza diagnostic assays utilize an analyzer reader device. (cdc.gov)
  • Three days after her illness onset (illness day four), she was seen by a health-care provider, who obtained a respiratory specimen and performed a rapid influenza diagnostic test, which was positive. (cdc.gov)
  • rapid influenza diagnostic testing was positive for both patients. (cdc.gov)
  • Despite measures to prevent HPAIV spread by vaccination or the culling of infected birds, several H5 influenza subtypes are already prevalent in Asia, Europe and Africa 4 . (nature.com)
  • Although the natural hosts of avian influenza viruses (AIVs) are wild birds, multiple subtypes of AIVs have established epidemics in numerous mammals due to their cross-species spillover. (flu.org.cn)
  • Handwashing and wearing masks, gloves, and gowns slow the spread of influenza and other respiratory viruses. (nursingcenter.com)
  • It is always a great concern when a new flu virus emerges, because the general population does not have immunity and almost everyone is susceptible to infection and disease. (bcm.edu)
  • Young people, those under 36 years old, may be at risk because they have no immunity to the virus. (breakingnewsenglish.com)
  • Therefore, further investigation and monitoring is required to prevent this novel reassortant virus from becoming a new threat to public health. (nature.com)
  • Furthermore, this virus was shown to be highly pathogenic to both birds and mammals and demonstrate tropism for the nervous system. (nature.com)
  • With the huge influenza A virus reservoir in wild birds, it is a cause for concern when a new influenza strain emerges with the ability to cross host species barrier, as shown in light of the recent H7N9 outbreak in China. (springer.com)
  • A new strain of flu virus has been discovered in fruit bats in Guatemala, according to the Centers for Disease Control and Prevention. (livescience.com)
  • These first clinical trials demonstrated a good serological response to both influenza A and B. After two doses, there was an eight- to ninefold increase in antibody titer, measured by the hemagglutination inhibition assay. (medscape.com)
  • Researchers from the Cluster of Excellence ImmunoSensation2 at the University of Bonn, together with Japanese researchers, want to exploit this for the treatment of influenza. (uni-bonn.de)
  • Influenza pneumonia: Amantadine hydrochloride and rimantadine hydrochloride are approved for the prevention and treatment of influenza A virus infection. (medscape.com)
  • Compared to pre-pandemic epidemiology this is an early start to the season for both these respiratory viruses. (constantcontact.com)
  • To monitor the epidemiology of canine influenza viruses (CIVs) in Liaoning, China, we performed three surveillances in November 2018, March 2019, and April 2019. (flu.org.cn)
  • A large number of influenza A viruses naturally reside in avian species where they constantly circulate and evolve. (springer.com)
  • A primer set (M52C/M253R) specific for We determined the prevalence of influenza A virus in dogs in a highly conserved region of matrix (M) gene was used for Taiwan and isolated A/canine/Taiwan/E01/2014. (cdc.gov)
  • positive by RT-PCR for influenza virus M gene. (cdc.gov)
  • Sequence homology of 8 influenza virus gene seg- ing, at the National Taiwan University Veterinary Hospital ments from A/canine/Taiwan/E01/2014 (H6N1) was com- during November 2012-February 2014. (cdc.gov)
  • All cases of human infection with S-OtrH3N2 virus containing the M gene from the pH1N1 virus have occurred in 2011 and have been reported from four states: Pennsylvania (three cases), Maine (two), Indiana (two), and Iowa (three) ( 3 ). (cdc.gov)
  • In previous research using gene sequence and phylogenetic analysis, we reported that H5N6 AIV isolated in February 2015 (ZH283) in Pallas's sandgrouse was highly similar to that isolated in a human in December 2015 (A/Guangdong/ZQ874/2015), whereas a virus (i.e. (frontiersin.org)
  • Genetic material, specifically DNA from the Type A influenza virus matrix gene, has been detected in sediment samples from waterfowl habitat. (usgs.gov)
  • Sentinel oysters deployed in cages to test for presence of the avian influenza virus matrix gene. (usgs.gov)
  • HI A/INDIANA/17/2013: Geometric mean hemagglutination inhibition (HI) titer against the influenza A/H3N2v virus A/Indiana/17/2013. (cdc.gov)
  • HI A/INDIANA/6/2013: Geometric mean hemagglutination inhibition (HI) titer against the influenza A/H3N2v virus A/Indiana/06/2013. (cdc.gov)
  • HI A/OHIO/13/2012: Geometric mean hemagglutination inhibition (HI) titer against the influenza A/H3N2v virus A/Ohio/13/2012. (cdc.gov)
  • Another surprising finding from the study was the rapid antibody response in the animals infected with the 1918 virus, which is not typically reported for the swine influenza virus. (scienceblog.com)
  • The antigens, matrix protein (M1) and nucleoprotein (NP), are used to determine if an influenza virus is type A, B, C, or D. The M1 protein is required for virus assembly and NP functions in transcription and replication. (wikipedia.org)
  • Tissue, cells or virus corresponding to Influenza A Virus Nucleoprotein. (abcam.com)
  • This co-immunoprecipitation protocol allows to study the interaction between the influenza A virus nucleoprotein and the antiviral Mx1 protein in human cells. (jove.com)
  • The protocol emphasizes the importance of N-ethylmaleimide for successful co-immunoprecipitation of Mx1 and influenza A virus nucleoprotein. (jove.com)
  • Influenza is one of the most well-known infectious diseases attracting attention worldwide. (springer.com)
  • But it was clear to Schmidt that the diagnostic technology his lab was developing for Zika virus and other infectious diseases could be adapted for COVID-19. (ucsc.edu)
  • The continuous improvement in laboratory capacity for influenza surveillance has helped drive the development of diagnostic and virology laboratories in the Global Influenza Surveillance and Response System (GISRS) in the Western Pacific Region, at the same time strengthening their ability to detect and respond to infectious threats beyond influenza. (who.int)
  • The remain- analysis indicated that this isolate was closely related to in- fluenza A(H6N1) viruses circulating in Taiwan and harbored ing nasal swab suspension solutions from dogs positive by the E627K substitution in the polymerase basic 2 protein, RT-PCR were used for virus isolation from 10-day-old spe- which indicated its ability to replicate in mammalian species. (cdc.gov)
  • Influenza D virus is a species in the virus genus Deltainfluenzavirus, in the family Orthomyxoviridae, that causes influenza. (wikipedia.org)
  • Metatranscriptomics studies have also identified closely related "Influenza C and D-like" viruses in a number of amphibian species. (wikipedia.org)
  • Most influenza A viruses are restricted to their host species, having limited capability to cross species barrier and infect a new host. (springer.com)
  • The virus continues to be active in non-domesticated bird reservoirs, and incidences of spillover and clinical disease in numerous animal species occur in European nations in 2021. (news-medical.net)
  • Read about the Global Influenza Hospital Surveillance Network, a new platform that can provide annual data on severe influenza for a wide range of populations. (medscape.com)
  • In addition, a monoclonal immunohistochemistry (IHC) examination for influenza A and canine distemper virus (CDV) antigen was performed. (news-medical.net)
  • The new chip-based antigen test is not only highly sensitive, but also enables simultaneous testing for multiple viruses from one sample. (ucsc.edu)
  • Among thousands of candidates, we were able to identify a molecule that inhibits MTr1 in human lung explants and also in vivo in mice, curtailing influenza replication," reports Prof. Hiroki Kato, a member of the Cluster of Excellence ImmunoSensation2 at the University of Bonn. (uni-bonn.de)
  • This reduction in transmission occurred when the mice were in contact with each other in a cage, and also when the virus was airborne, that is, spreading to uninfected mice who were separated from infected mice by a perforated barrier. (fda.gov)
  • Here, we show that coinfection of the upper respiratory tract of mice with influenza virus and pneumococcus leads to synergistic stimulation of type I IFNs and that this impairs the recruitment of macrophages, which are required for pneumococcal clearance, due to decreased production of the chemokine CCL2. (nih.gov)
  • Indeed, the increased colonization associated with concurrent influenza virus infection was not observed in mice lacking Nod2 or the type I IFN receptor, or in mice challenged with pneumococci lacking pneumolysin. (nih.gov)
  • A Kansas State University researcher has found that the virus causing the pandemic was able to infect and replicate in pigs, but did not kill them, unlike in other mammalian hosts like monkeys, mice and ferrets where the infection has been lethal. (scienceblog.com)
  • This was surprising, since the 1918 virus killed more than 20 million people and was lethal to ferrets, mice and macaques. (scienceblog.com)
  • Remarkably, influenza viruses passaged through Ifitm3-/- mice exhibited enhanced host adaptation , a result that was distinct from passaging in mice deficient for interferon signaling, which caused virus attenuation. (bvsalud.org)
  • Influenza B viruses cause the same spectrum of disease as influenza A. However, influenza B viruses do not cause pandemics. (virology.ws)
  • Influenza virus pandemics are caused by viruses from animal reservoirs that adapt to efficiently infect and replicate in human hosts. (bvsalud.org)
  • Preliminary research on the new virus suggests that its genes are compatible with human influenza viruses , the CDC said. (livescience.com)
  • These four viruses have been selected because they have NS1 genes that belong to the A and B alleles, respectively. (usda.gov)
  • We anticipate that NS1 mediates the effects of AIV on macrophages and would like to test viruses with different NS1 alleles to determine if it mediates the downregulation of immune function genes as we described in the Prelimiary Results. (usda.gov)
  • Reverse genetics: NS1 genes will be altered through site mutagenesis and mutated viruses will be generated through co-transfection of macropahges with a reverse genetics system to determine which part of the NS1 genes is responsible for the observed differences in cytopathogenic effect (apoptosis) and the modulation of the immnue genes detected by microarray analysis. (usda.gov)
  • 1. Extensive Regulations of immune genes in chicken macrophages and lungs infected with influenza virus H9N2. (usda.gov)
  • We also found that interferon (IFN) and IFN-inducible genes were regulated differentially in A/ph/CA/2373/98 (H9N2) virus infected Macrophages. (usda.gov)
  • In addition to total nucleic acid extraction and ribonucleic acid (RNA) separation, the researchers used reverse transcription-polymerase chain reaction (RT-PCR) to target the conserved site of the influenza A virus (IAV) matrix genes. (news-medical.net)
  • Do viruses ever reassort across these lines-like influenza A and C exchanging HA genes or something? (virology.ws)
  • However, at this time, there was no definitive confirmation of clinical protection, because the influenza epidemic during the 1942-1943 winter was mild. (medscape.com)
  • The virus could start a worldwide flu epidemic if it gets into the human population. (breakingnewsenglish.com)
  • The virus could start a worldwide flu epidemic. (breakingnewsenglish.com)
  • Microorganism, microscopic bacteria, pandemic virus, epidemic germs under magnifying glass vector medical and contamination concept. (clipart.com)
  • Healthy and Covid 19 virus epidemic Concept. (vecteezy.com)
  • In Mexico, influenza circulation in the last four EWs has remained at epidemic levels, and ILI and SARI activity continue to decline, with the majority of cases being associated with SARS-CoV-2 and to a lesser extent, influenza. (paho.org)
  • In El Salvador, RSV activity continues to be high but is decreasing, SARS-CoV-2 activity has remained low over the last three EWs, and influenza activity has shown a slight increase, reaching epidemic levels. (paho.org)
  • In Nicaragua, influenza activity has decreased in the last EW and remains at epidemic levels. (paho.org)
  • What are the diagnostic practices for influenza and other respiratory virus in U.S. hospitals and laboratories? (medscape.com)
  • IDPH has instructed health-care providers to obtain respiratory specimens from patients with ILI for influenza diagnostic testing at SHL. (cdc.gov)
  • Every few decades or so, a new version of the influenza virus emerges in the human population that causes a serious global outbreak of disease called a pandemic . (bcm.edu)
  • NON-TECHNICAL SUMMARY: Avian influenza is one of the most important diseases of poultry. (usda.gov)
  • Thorough cooking of poultry meat and eggs, with centre temperature reaching at least 70°C, can prevent avian influenza infection as it inactivates the virus. (gov.hk)
  • However, it is important to verify that these phenomena remain sporadic and that the viruses that have acquired this ability to cross into mammals are not detected on poultry farms. (anses.fr)
  • transcription PCR (RT-PCR) screening, and virus isolation. (cdc.gov)
  • Isolation of influenza C virus recombinants. (virology.ws)
  • Innate immune control of influenza virus interspecies adaptation. (bvsalud.org)
  • Here, we investigated whether Interferon -Induced Transmembrane Protein 3 (IFITM3), a host antiviral factor with known human deficiencies, plays a role in interspecies virus infection and adaptation. (bvsalud.org)
  • (https://www.who.int/influenza/pip/2016RGRecTracking_Oct2018.pdf, accessed 10 December 2018). (who.int)
  • The team led by Prof. Hiroki Kato from the Institute of Cardiovascular Immunology at the University Hospital Bonn has identified a compound that inhibits the body's own methyltransferase MTr1, thereby limiting the replication of influenza viruses. (uni-bonn.de)
  • The activity of MTr1 is thus essential for the replication of the influenza virus in the cell. (uni-bonn.de)
  • We also show that a nanobody (a single-domain antibody) that interferes with FluPol A dimerization inhibits the synthesis of vRNA and, consequently, inhibits virus replication in infected cells. (nature.com)
  • Fig. 4: Nb8205, which binds FluPol A at the dimer interface, inhibits cRNA to vRNA replication and virus growth. (nature.com)